Query 021200
Match_columns 316
No_of_seqs 253 out of 1567
Neff 5.4
Searched_HMMs 46136
Date Fri Mar 29 08:23:06 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/021200.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/021200hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 COG0216 PrfA Protein chain rel 100.0 2E-114 4E-119 822.1 31.4 313 1-314 49-362 (363)
2 TIGR00019 prfA peptide chain r 100.0 2.2E-98 5E-103 726.7 36.3 311 1-314 49-359 (360)
3 PRK00591 prfA peptide chain re 100.0 1.5E-97 3E-102 721.1 37.2 310 2-313 49-358 (359)
4 PRK06746 peptide chain release 100.0 9.3E-95 2E-99 692.2 34.5 296 1-303 27-324 (326)
5 PRK05589 peptide chain release 100.0 8.2E-94 1.8E-98 686.5 34.9 295 1-303 27-323 (325)
6 PRK08787 peptide chain release 100.0 1.7E-93 3.7E-98 679.2 33.8 296 2-306 7-305 (313)
7 PRK07342 peptide chain release 100.0 6.1E-93 1.3E-97 682.7 33.6 294 2-304 30-327 (339)
8 PRK00578 prfB peptide chain re 100.0 7.6E-93 1.6E-97 690.4 34.3 299 1-306 65-365 (367)
9 TIGR00020 prfB peptide chain r 100.0 9.7E-93 2.1E-97 688.6 34.7 296 1-303 65-362 (364)
10 KOG2726 Mitochondrial polypept 100.0 6.9E-91 1.5E-95 671.6 29.6 309 3-313 75-385 (386)
11 COG1186 PrfB Protein chain rel 100.0 1.5E-72 3.3E-77 517.0 18.0 235 67-303 1-237 (239)
12 TIGR03072 release_prfH putativ 100.0 3.2E-66 7E-71 467.3 24.0 197 67-268 1-198 (200)
13 PRK08179 prfH peptide chain re 100.0 4.4E-65 9.6E-70 459.9 22.8 195 67-267 2-198 (200)
14 PF00472 RF-1: RF-1 domain; I 100.0 2.8E-38 6.1E-43 262.7 11.7 110 167-276 4-113 (113)
15 PF03462 PCRF: PCRF domain; I 100.0 9.5E-33 2.1E-37 230.0 12.4 112 23-134 4-115 (115)
16 PRK09256 hypothetical protein; 99.9 1.1E-22 2.5E-27 174.7 7.6 70 169-238 7-100 (138)
17 KOG3429 Predicted peptidyl-tRN 99.6 6.6E-16 1.4E-20 134.9 6.8 71 168-238 33-128 (172)
18 PF04350 PilO: Pilus assembly 68.5 11 0.00024 31.3 5.1 43 84-126 52-97 (144)
19 PF09032 Siah-Interact_N: Siah 66.7 18 0.00039 28.7 5.5 45 5-50 3-47 (79)
20 PF13710 ACT_5: ACT domain; PD 52.8 39 0.00084 25.0 5.0 38 88-125 6-43 (63)
21 KOG3274 Uncharacterized conser 50.0 14 0.00031 34.0 2.7 110 88-204 76-185 (210)
22 PRK06737 acetolactate synthase 43.7 65 0.0014 25.1 5.2 39 88-126 16-54 (76)
23 PRK11152 ilvM acetolactate syn 37.5 67 0.0014 25.0 4.4 41 88-128 17-57 (76)
24 PF15188 CCDC-167: Coiled-coil 37.5 1.7E+02 0.0037 23.5 6.8 48 7-54 14-61 (85)
25 PF00587 tRNA-synt_2b: tRNA sy 37.3 1.3E+02 0.0028 25.9 6.7 49 74-123 118-167 (173)
26 PRK13562 acetolactate synthase 36.3 88 0.0019 25.1 4.9 37 90-126 18-55 (84)
27 COG3881 PRC-barrel domain cont 35.8 58 0.0013 29.3 4.2 48 96-145 6-55 (176)
28 KOG1489 Predicted GTP-binding 35.0 1.2E+02 0.0026 30.4 6.6 105 67-189 45-161 (366)
29 PF02815 MIR: MIR domain; Int 34.3 64 0.0014 28.5 4.4 37 180-216 122-158 (190)
30 PRK06342 transcription elongat 34.0 95 0.0021 27.5 5.3 52 5-57 34-85 (160)
31 PF11553 DUF3231: Protein of u 33.9 2.6E+02 0.0056 24.2 8.1 55 3-58 22-76 (166)
32 PF14257 DUF4349: Domain of un 32.9 1.7E+02 0.0037 27.3 7.2 49 3-52 137-185 (262)
33 PRK05431 seryl-tRNA synthetase 31.1 2.7E+02 0.0059 28.3 8.8 69 1-69 31-123 (425)
34 PF15466 DUF4635: Domain of un 29.1 25 0.00053 30.1 0.7 47 259-305 55-108 (135)
35 PF13450 NAD_binding_8: NAD(P) 27.9 1.2E+02 0.0026 22.4 4.3 36 97-141 17-53 (68)
36 smart00322 KH K homology RNA-b 23.2 1.3E+02 0.0027 20.6 3.5 45 186-233 19-68 (69)
37 cd05569 PTS_IIB_fructose PTS_I 21.7 2.4E+02 0.0052 22.4 5.2 37 68-108 2-38 (96)
38 PF08014 DUF1704: Domain of un 21.2 2.8E+02 0.006 27.6 6.6 123 25-154 39-187 (349)
39 PRK11020 hypothetical protein; 21.1 5.2E+02 0.011 22.1 7.1 46 5-50 5-52 (118)
40 cd07881 RHD-n_NFAT N-terminal 21.1 1.5E+02 0.0033 26.6 4.2 26 188-213 134-164 (175)
41 cd02394 vigilin_like_KH K homo 20.9 1.2E+02 0.0027 21.5 3.1 20 186-205 16-37 (62)
42 PF02185 HR1: Hr1 repeat; Int 20.6 3.6E+02 0.0079 20.0 6.2 54 4-57 7-61 (70)
No 1
>COG0216 PrfA Protein chain release factor A [Translation, ribosomal structure and biogenesis]
Probab=100.00 E-value=1.8e-114 Score=822.05 Aligned_cols=313 Identities=53% Similarity=0.869 Sum_probs=305.2
Q ss_pred ChHHHHHHHHHHHHHHHHHhHhhcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCeeEEEEcCCCcHHH
Q 021200 1 MHLISELRTKQKEIDGLKSLIYECSEDKDMLDMATEELCLAIDEEKRLQSLLLKSLLPKDDADERDCILEVRAGTGGEEA 80 (316)
Q Consensus 1 ~~~~~~~~~~~~el~el~~l~~e~~~D~em~e~a~eE~~~l~~~l~~le~~l~~~llp~~~~d~~~~~leI~aG~Gg~Ea 80 (316)
+.+|++|+++..+++++++|+.+. .|+||++||++|+..++++++.|+++|..+|||+||.|+.||||||+||+||+||
T Consensus 49 v~~~~~~~~~~~~l~~a~~~l~~~-~D~em~ema~~Ei~~~~~~~~~le~~L~~lLlPkDpnd~knvilEIRagtGGdEA 127 (363)
T COG0216 49 VEKYREYKKAQEDLEDAKEMLAEE-KDPEMREMAEEEIKELEAKIEELEEELKILLLPKDPNDDKNIILEIRAGTGGDEA 127 (363)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhcc-CCHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCCCCcCeEEEEecCCCchHH
Confidence 368999999999999999999873 7999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHcCCeEEEEeeccCCCCCceEEEEEEeccccccceeeecceeEEEEeccccCCCCeeeceeEEE
Q 021200 81 SLFAVDVFKMYERYSQKKGWKFEVVGVTESDLRGYKEASAAISGVGVYGKLKFESGIHRVQRVPLTEKSGRVHTSAVSVA 160 (316)
Q Consensus 81 ~~~~~~L~~my~~~a~~~g~~~~~~~~~~~~~~g~~~~~~~i~G~~ay~~l~~E~GvHrv~rvp~~~~~gR~hts~~~V~ 160 (316)
++||++||+||.+||+.+||++++++.++++.||||.+++.|+|.+||+.||||+|||||||||.|+++||+|||+|+|+
T Consensus 128 alFagDLfrMY~rYAe~kgWk~ei~s~se~~~GG~kEii~~I~G~gvys~LKfEsGvHRVQRVP~TEsqGRIHTStaTVa 207 (363)
T COG0216 128 ALFAGDLFRMYSRYAESKGWKVEILSASESELGGYKEIIASISGKGVYSRLKFESGVHRVQRVPATESQGRIHTSAATVA 207 (363)
T ss_pred HHHHHHHHHHHHHHHHhCCCEEEEeecCcccCCCceEEEEEEeccchhhhhhhccCccceeccccccCCCceeecceeEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EecCCCcc-ccccCCCCeEEEeeecCCCCCccccccCceEEEEeeCCceEEEEcCcCcHHHHHHHHHHHHHHHHHHHHHH
Q 021200 161 ILPQADEV-DVRLRNEDLRIDTYRSGGSGGQHANTTNSAVRVTHIPTGMTISIQDERSQHMNKAKALKVLCAKLYEMERS 239 (316)
Q Consensus 161 vlP~~~~~-~~~i~~~dl~~~~~RssGpGGQ~VNkt~saVrl~h~ptgi~v~~~~~RSq~~Nk~~A~~~L~~~L~~~~~~ 239 (316)
|||++++. ++.|+|+||+|+||||||+||||||||+|||||||+||||+|+||++||||+||++||+.|++||++++.+
T Consensus 208 VlPE~ee~~ei~I~~~DlrIDt~RsSGaGGQhVNtTdSAVRiTHlPTGIvV~cQderSQ~kNk~kAmkvL~ARl~~~~~~ 287 (363)
T COG0216 208 VLPEVEEVEEIEINPKDLRIDTFRSSGAGGQHVNTTDSAVRITHLPTGIVVECQDERSQHKNKAKAMKVLRARLYDAERQ 287 (363)
T ss_pred eccCCCcccccccChHHceeeeeecCCCCCCCcCccchhheeeecCCceEEEecchhhhhhhHHHHHHHHHHHHHHHHHH
Confidence 99999875 79999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhHhhcccccCCCCCceeEeecCCCceeeccccceecCcccccCCcChHHHHHHHHHHHHHHHHHcccC
Q 021200 240 RIHLSRSKLRSEQIGSGDRSERIRTYNFPQGRVTDHRVGITHHAISDMMEGENLDIFIDALLLQQEMDAIASFGS 314 (316)
Q Consensus 240 ~~~~~~~~~r~~~~~~~~rse~IRtYnf~~~rVtDhR~~~~~~~l~~vl~G~~ld~~i~~l~~~~~~~~~~~~~~ 314 (316)
++.++.++.|++|+|+|+||++|||||||||||||||||+++++|+.||+|.+||++|++|+.++++++|+++..
T Consensus 288 ~~~~~~~~~RksqVGSGDRSErIRTYNfPQnRVTDHRI~lTl~kLd~vm~gG~LDeii~aLi~~~q~~~L~~l~~ 362 (363)
T COG0216 288 KAQAEEASERKSQVGSGDRSERIRTYNFPQNRVTDHRINLTLYKLDEVMEGGKLDEIIDALIAEDQAEQLAELGE 362 (363)
T ss_pred HHHHHHHHHHHHhcCCCchhhhhhccCCCCCcccchhcccccccHHHHhccCcHHHHHHHHHHHHHHHHHHHhhc
Confidence 999999999999999999999999999999999999999999999999994379999999999999999998764
No 2
>TIGR00019 prfA peptide chain release factor 1. This model describes peptide chain release factor 1 (PrfA, RF-1), and excludes the related peptide chain release factor 2 (PrfB, RF-2). RF-1 helps recognize and terminate translation at UAA and UAG stop codons. The mitochondrial release factors are prfA-like, although not included above the trusted cutoff for this model. RF-1 does not have a translational frameshift.
Probab=100.00 E-value=2.2e-98 Score=726.72 Aligned_cols=311 Identities=52% Similarity=0.863 Sum_probs=301.3
Q ss_pred ChHHHHHHHHHHHHHHHHHhHhhcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCeeEEEEcCCCcHHH
Q 021200 1 MHLISELRTKQKEIDGLKSLIYECSEDKDMLDMATEELCLAIDEEKRLQSLLLKSLLPKDDADERDCILEVRAGTGGEEA 80 (316)
Q Consensus 1 ~~~~~~~~~~~~el~el~~l~~e~~~D~em~e~a~eE~~~l~~~l~~le~~l~~~llp~~~~d~~~~~leI~aG~Gg~Ea 80 (316)
++.|++|..+..++.++.+|+++ +|++|+++|.+|+..+..+++.++.++...|+|++|+|.++|+|+|+||+||+||
T Consensus 49 v~~~~~~~~~~~~~~~~~el~~~--~D~e~~~~a~~e~~~l~~~~~~~e~~l~~~ll~~~~~D~~~~~leI~aG~GG~Ea 126 (360)
T TIGR00019 49 VDCYREYQQAQEDIKEAKEILEE--SDPEMREMAKEELEELEEKIEELEEQLKVLLLPKDPNDEKNVILEIRAGTGGDEA 126 (360)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCCCcCCCeEEEEECCCCcHHH
Confidence 35788899999999999999965 6999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHcCCeEEEEeeccCCCCCceEEEEEEeccccccceeeecceeEEEEeccccCCCCeeeceeEEE
Q 021200 81 SLFAVDVFKMYERYSQKKGWKFEVVGVTESDLRGYKEASAAISGVGVYGKLKFESGIHRVQRVPLTEKSGRVHTSAVSVA 160 (316)
Q Consensus 81 ~~~~~~L~~my~~~a~~~g~~~~~~~~~~~~~~g~~~~~~~i~G~~ay~~l~~E~GvHrv~rvp~~~~~gR~hts~~~V~ 160 (316)
++||++||+||.+||+++||++++++..+++.+||++|++.|+|++||++|++|+|||||||||+|+++||+||||++|+
T Consensus 127 ~~~a~~Ll~mY~~~a~~~g~~~~vi~~~~~~~~g~ksa~l~i~G~~ay~~lk~E~GvHrv~Rvp~~~s~~R~hTsfa~V~ 206 (360)
T TIGR00019 127 AIFAGDLFRMYSRYAESKGWKVEILSANETELGGYKEVIAEIKGDGVYSRLKFESGVHRVQRVPVTESQGRIHTSAATVA 206 (360)
T ss_pred HHHHHHHHHHHHHHHHHCCCEEEEEecCCCCCCcceEEEEEEecccHHHHHhhcCeeEEEECCCCCCCCCCeecceeEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccCCCCeEEEeeecCCCCCccccccCceEEEEeeCCceEEEEcCcCcHHHHHHHHHHHHHHHHHHHHHHH
Q 021200 161 ILPQADEVDVRLRNEDLRIDTYRSGGSGGQHANTTNSAVRVTHIPTGMTISIQDERSQHMNKAKALKVLCAKLYEMERSR 240 (316)
Q Consensus 161 vlP~~~~~~~~i~~~dl~~~~~RssGpGGQ~VNkt~saVrl~h~ptgi~v~~~~~RSq~~Nk~~A~~~L~~~L~~~~~~~ 240 (316)
|+|.+++.++.|+++||+|+|+|||||||||||||+|||||+|+||||+|.||++|||++||+.|+++|+++|++...++
T Consensus 207 v~P~~~~~~~~i~~~dl~~~~~RssG~GGQ~VNkt~SaVrl~h~ptgi~V~~~~eRSQ~~Nk~~A~~~L~~~L~~~~~~~ 286 (360)
T TIGR00019 207 VMPELEEVEVDINPADLRIDTFRSSGAGGQHVNTTDSAVRITHLPTGIVVECQDERSQHKNKDKAMKVLRARLYEAEQEK 286 (360)
T ss_pred EEcCCCccccccCcccEEEEEEECCCCCCCCcCceeeeEEEEECCCcEEEEECCccCHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999878899999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred HHHHHhhHhhcccccCCCCCceeEeecCCCceeeccccceecCcccccCCcChHHHHHHHHHHHHHHHHHcccC
Q 021200 241 IHLSRSKLRSEQIGSGDRSERIRTYNFPQGRVTDHRVGITHHAISDMMEGENLDIFIDALLLQQEMDAIASFGS 314 (316)
Q Consensus 241 ~~~~~~~~r~~~~~~~~rse~IRtYnf~~~rVtDhR~~~~~~~l~~vl~G~~ld~~i~~l~~~~~~~~~~~~~~ 314 (316)
+.++....|++++++++||+|||||||||+||||||||++++||++||+| +||+||++++.++++++|+++.+
T Consensus 287 ~~~~~~~~r~~~~~~~~Rs~~IRtY~~~~~rV~DhRtg~~~~~l~~vl~G-~Ld~~I~~~l~~~~~~~l~~~~~ 359 (360)
T TIGR00019 287 QQAAQASTRKSQVGSGDRSERIRTYNFPQNRVTDHRINLTLYKLDEVLEG-DLDELIEALIAEDQAQQLAALSE 359 (360)
T ss_pred HHHHHHHHHhhhcceecccCCeEEEECCCCeeeeeccCCeEcChHHHhCC-chHHHHHHHHHHHHHHHHHHHhh
Confidence 99999999999999999999999999999999999999999999999999 69999999999999999988754
No 3
>PRK00591 prfA peptide chain release factor 1; Validated
Probab=100.00 E-value=1.5e-97 Score=721.09 Aligned_cols=310 Identities=54% Similarity=0.894 Sum_probs=301.5
Q ss_pred hHHHHHHHHHHHHHHHHHhHhhcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCeeEEEEcCCCcHHHH
Q 021200 2 HLISELRTKQKEIDGLKSLIYECSEDKDMLDMATEELCLAIDEEKRLQSLLLKSLLPKDDADERDCILEVRAGTGGEEAS 81 (316)
Q Consensus 2 ~~~~~~~~~~~el~el~~l~~e~~~D~em~e~a~eE~~~l~~~l~~le~~l~~~llp~~~~d~~~~~leI~aG~Gg~Ea~ 81 (316)
+.|++|.....++.++.+|+.+ ++|++|+++|++|+..+..++++++.+|...|+|++|+|.++|+|+|+||+||+||+
T Consensus 49 ~~~~~~~~~~~~~~~~~~l~~~-e~D~~~~~~~~~e~~~l~~~l~~~e~~l~~~ll~~~~~D~~~~~leI~aG~GG~Ea~ 127 (359)
T PRK00591 49 EAYREYKQAQEDLEEAKEMLEE-ESDPEMREMAKEELKELEERLEELEEELKILLLPKDPNDDKNVILEIRAGTGGDEAA 127 (359)
T ss_pred HHHHHHHHHHHHHHHHHHHHhc-cCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccCCeEEEEECCCChHHHH
Confidence 5788999999999999999974 579999999999999999999999999888899999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHcCCeEEEEeeccCCCCCceEEEEEEeccccccceeeecceeEEEEeccccCCCCeeeceeEEEE
Q 021200 82 LFAVDVFKMYERYSQKKGWKFEVVGVTESDLRGYKEASAAISGVGVYGKLKFESGIHRVQRVPLTEKSGRVHTSAVSVAI 161 (316)
Q Consensus 82 ~~~~~L~~my~~~a~~~g~~~~~~~~~~~~~~g~~~~~~~i~G~~ay~~l~~E~GvHrv~rvp~~~~~gR~hts~~~V~v 161 (316)
+||++|++||.+||+++||++++++..+++.+||++|++.|+|++||++|++|+|||||||||+|+++||+||||++|+|
T Consensus 128 ~~a~~Ll~mY~~~a~~~g~~~~vi~~~~~~~~g~ksa~l~i~G~~ay~~Lk~E~GvHrv~R~p~~~s~~R~~tsfa~V~v 207 (359)
T PRK00591 128 LFAGDLFRMYSRYAERQGWKVEILSASEGELGGYKEVIAEISGDGVYSKLKFESGVHRVQRVPATESQGRIHTSAATVAV 207 (359)
T ss_pred HHHHHHHHHHHHHHHHCCCEEEEEecCCCCCCceeEEEEEEecccHHHHHhhcCeeEEEEeeCCCCCCCceecceEEEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCeEEEeeecCCCCCccccccCceEEEEeeCCceEEEEcCcCcHHHHHHHHHHHHHHHHHHHHHHHH
Q 021200 162 LPQADEVDVRLRNEDLRIDTYRSGGSGGQHANTTNSAVRVTHIPTGMTISIQDERSQHMNKAKALKVLCAKLYEMERSRI 241 (316)
Q Consensus 162 lP~~~~~~~~i~~~dl~~~~~RssGpGGQ~VNkt~saVrl~h~ptgi~v~~~~~RSq~~Nk~~A~~~L~~~L~~~~~~~~ 241 (316)
+|.+++.++.|+++||+|+|+|||||||||||||+|||||+|+||||+|+|+++|||++||+.|+++|+++|++.+.+++
T Consensus 208 ~P~~~~~~~~i~~~dl~~~~~RssG~GGQ~VNkt~saVrl~H~ptGi~v~~~~eRSQ~~Nk~~Al~~L~~~L~~~~~~~~ 287 (359)
T PRK00591 208 LPEAEEVEVEINPKDLRIDTFRSSGAGGQHVNTTDSAVRITHLPTGIVVECQDERSQHKNKAKAMKVLRARLYDAERQKA 287 (359)
T ss_pred EcCCCccccccCcccEEEEEEECCCCCCCCccceeeeEEEEECCCcEEEEECCcCCHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99998888999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhHhhcccccCCCCCceeEeecCCCceeeccccceecCcccccCCcChHHHHHHHHHHHHHHHHHccc
Q 021200 242 HLSRSKLRSEQIGSGDRSERIRTYNFPQGRVTDHRVGITHHAISDMMEGENLDIFIDALLLQQEMDAIASFG 313 (316)
Q Consensus 242 ~~~~~~~r~~~~~~~~rse~IRtYnf~~~rVtDhR~~~~~~~l~~vl~G~~ld~~i~~l~~~~~~~~~~~~~ 313 (316)
.++++..|++++++++||++||||||||+||||||||++++||++||+| +||+||++++.++++++|.++.
T Consensus 288 ~~~~~~~r~~~~~~~~Rse~IRtY~f~~~~V~DhRtg~~~~~l~~vl~G-~Ld~fI~~~l~~~~~~~l~~~~ 358 (359)
T PRK00591 288 QAEEAATRKSQVGSGDRSERIRTYNFPQGRVTDHRINLTLYKLDEVMEG-DLDELIDALIAEDQAEKLAALG 358 (359)
T ss_pred HHHHHHHHHhhcccccccCCeeeEECCCCeeeeeccCCEEcChHHHhCC-ChHHHHHHHHHHHHHHHHHhhc
Confidence 9999999999999999999999999999999999999999999999999 6999999999999999998875
No 4
>PRK06746 peptide chain release factor 2; Provisional
Probab=100.00 E-value=9.3e-95 Score=692.21 Aligned_cols=296 Identities=37% Similarity=0.582 Sum_probs=283.2
Q ss_pred ChHHHHHHHHHHHHHHHHHhHhhcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCeeEEEEcCCCcHHH
Q 021200 1 MHLISELRTKQKEIDGLKSLIYECSEDKDMLDMATEELCLAIDEEKRLQSLLLKSLLPKDDADERDCILEVRAGTGGEEA 80 (316)
Q Consensus 1 ~~~~~~~~~~~~el~el~~l~~e~~~D~em~e~a~eE~~~l~~~l~~le~~l~~~llp~~~~d~~~~~leI~aG~Gg~Ea 80 (316)
++.|++|.+..+++.++.+|+.+ ++|++|++||++|++.+.+++++++ ..++|++|+|.++|+|||+||+||+||
T Consensus 27 v~~~~~~~~~~~d~~~~~el~~~-~~d~e~~~~a~~e~~~l~~~l~~le----~~~l~~~~~D~~~~~leI~aG~GG~Ea 101 (326)
T PRK06746 27 VGKFRQLDETFENLEITHELLKE-EYDEDLHEELESEVKGLIQEMNEYE----LQLLLSDPYDKNNAILELHPGAGGTES 101 (326)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhc-cCCHHHHHHHHHHHHHHHHHHHHHH----HHhccCCCCccCCeEEEEECCCCcHHH
Confidence 36789999999999999999965 5699999999999999999999986 357789999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHcCCeEEEEeeccCCCCCceEEEEEEeccccccceeeecceeEEEEeccccCCCCeeeceeEEE
Q 021200 81 SLFAVDVFKMYERYSQKKGWKFEVVGVTESDLRGYKEASAAISGVGVYGKLKFESGIHRVQRVPLTEKSGRVHTSAVSVA 160 (316)
Q Consensus 81 ~~~~~~L~~my~~~a~~~g~~~~~~~~~~~~~~g~~~~~~~i~G~~ay~~l~~E~GvHrv~rvp~~~~~gR~hts~~~V~ 160 (316)
++||++||+||.+||+++||++++++..+++.+||++|++.|+|++||++|++|+|||||||+|+|+++||+|||||+|+
T Consensus 102 ~~~a~~Ll~MY~r~a~~~g~~~evi~~~~~~~~g~ksa~l~i~G~~ay~~lk~E~GvHrv~Rvsp~~s~~rrhTsfa~V~ 181 (326)
T PRK06746 102 QDWGSMLLRMYTRWAEKRGFKVETVDYLPGDEAGIKSVTLLIKGHNAYGYLKAEKGVHRLVRISPFDSSGRRHTSFVSCE 181 (326)
T ss_pred HHHHHHHHHHHHHHHHHcCCEEEEEecCCCCCCceEEEEEEEeccCHHHHHhhccceEEEEecCCCCCCCCeEeeEEEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EecCCC-ccccccCCCCeEEEeeecCCCCCccccccCceEEEEeeCCceEEEEcCcCcHHHHHHHHHHHHHHHHHHHHHH
Q 021200 161 ILPQAD-EVDVRLRNEDLRIDTYRSGGSGGQHANTTNSAVRVTHIPTGMTISIQDERSQHMNKAKALKVLCAKLYEMERS 239 (316)
Q Consensus 161 vlP~~~-~~~~~i~~~dl~~~~~RssGpGGQ~VNkt~saVrl~h~ptgi~v~~~~~RSq~~Nk~~A~~~L~~~L~~~~~~ 239 (316)
|+|.++ ++++.|+++||+|+|+|||||||||||||+|||||+|+||||+|+||++|||++||+.|+++|++||++.+.+
T Consensus 182 v~P~~~~~~~i~i~~~dl~~~~~rssG~GGQ~vNkt~saVrl~h~ptgi~v~~q~~RSQ~~Nk~~A~~~L~akL~~~~~~ 261 (326)
T PRK06746 182 VVPEFNDEVEIEVRTEDLKIDTYRASGAGGQHVNTTDSAVRITHTPTNTVVTCQSERSQIKNREHAMKMLKAKLYQKKLE 261 (326)
T ss_pred EecCcCCccccccChHHeEEEEEeCCCCCCCCccceeeEEEEEEeCCeEEEEECCCCCHHHHHHHHHHHHHHHHHHHHHH
Confidence 999984 6889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhHhhcccccCCCCCceeEeec-CCCceeeccccceecCcccccCCcChHHHHHHHHHH
Q 021200 240 RIHLSRSKLRSEQIGSGDRSERIRTYNF-PQGRVTDHRVGITHHAISDMMEGENLDIFIDALLLQ 303 (316)
Q Consensus 240 ~~~~~~~~~r~~~~~~~~rse~IRtYnf-~~~rVtDhR~~~~~~~l~~vl~G~~ld~~i~~l~~~ 303 (316)
++.++.+..|+++++ ..||++|||||| ||+||||||||++++||+.||+| +||+||++++.+
T Consensus 262 ~~~~~~~~~r~~~~~-~~rg~~IRtYnf~p~~rVtDhR~~~~~~~l~~vl~G-~ld~~I~~~~~~ 324 (326)
T PRK06746 262 EQQAELDEIRGEQKE-IGWGSQIRSYVFHPYSLVKDHRTNTEVGNVQAVMDG-EIDPFIDAYLRS 324 (326)
T ss_pred HHHHHHHHHHhhhcc-CccCCCeEEEECCCCceeeeeecCceecChHHhhCC-CHHHHHHHHHHc
Confidence 999999999998876 489999999999 99999999999999999999999 699999999875
No 5
>PRK05589 peptide chain release factor 2; Provisional
Probab=100.00 E-value=8.2e-94 Score=686.46 Aligned_cols=295 Identities=37% Similarity=0.614 Sum_probs=278.9
Q ss_pred ChHHHHHHHHHHHHHHHHHhHhhcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCeeEEEEcCCCcHHH
Q 021200 1 MHLISELRTKQKEIDGLKSLIYECSEDKDMLDMATEELCLAIDEEKRLQSLLLKSLLPKDDADERDCILEVRAGTGGEEA 80 (316)
Q Consensus 1 ~~~~~~~~~~~~el~el~~l~~e~~~D~em~e~a~eE~~~l~~~l~~le~~l~~~llp~~~~d~~~~~leI~aG~Gg~Ea 80 (316)
++.|+.|....+++.++.+|+.+ +|++|+++|.+|+..++++++.++ ..+||++|+|.++|+|||+||+||+||
T Consensus 27 v~~~~~~~~~~~~~~~~~~l~~~--~d~e~~~~a~~e~~~l~~~l~~~e----~~~l~~~~~D~~~~~leI~aG~GG~Ea 100 (325)
T PRK05589 27 LDKYNHLRNRIEDIEVLCEMMSE--EDDEMKKEIISEVKNIKEEIDRFK----IETLLSGEYDRNNAILTLHSGVGGTDA 100 (325)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhh--cCHHHHHHHHHHHHHHHHHHHHHH----HHhcCCCCCcCCCeEEEEECCCCchHH
Confidence 35788999999999999999964 478899999999999999998876 566778999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHcCCeEEEEeeccCCCCCceEEEEEEeccccccceeeecceeEEEEeccccCCCCeeeceeEEE
Q 021200 81 SLFAVDVFKMYERYSQKKGWKFEVVGVTESDLRGYKEASAAISGVGVYGKLKFESGIHRVQRVPLTEKSGRVHTSAVSVA 160 (316)
Q Consensus 81 ~~~~~~L~~my~~~a~~~g~~~~~~~~~~~~~~g~~~~~~~i~G~~ay~~l~~E~GvHrv~rvp~~~~~gR~hts~~~V~ 160 (316)
++||++||+||.+||+++||++++++..+++.+||++|++.|+|++||++|++|+|||||||+|+|+++||+||||++|+
T Consensus 101 ~~fa~~L~~mY~~~a~~~g~~~~vi~~~~~~~~g~ks~~~~i~G~~ay~~lk~E~GvHrv~r~s~~~~~~rr~ts~a~V~ 180 (325)
T PRK05589 101 QDWTEMLLRMYTRWAEKKGYKVEIIDLLEGDEAGIKSVTLKITGEFAYGYLKAEKGIHRLVRISPFNANGKRQTSFASVE 180 (325)
T ss_pred HHHHHHHHHHHHHHHHHcCCEEEEEecCCCCCCceEEEEEEEeccCHHHHHhhccceEEEEEcCCCCCCCCeEeeeEEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EecCCCc-cccccCCCCeEEEeeecCCCCCccccccCceEEEEeeCCceEEEEcCcCcHHHHHHHHHHHHHHHHHHHHHH
Q 021200 161 ILPQADE-VDVRLRNEDLRIDTYRSGGSGGQHANTTNSAVRVTHIPTGMTISIQDERSQHMNKAKALKVLCAKLYEMERS 239 (316)
Q Consensus 161 vlP~~~~-~~~~i~~~dl~~~~~RssGpGGQ~VNkt~saVrl~h~ptgi~v~~~~~RSq~~Nk~~A~~~L~~~L~~~~~~ 239 (316)
|+|.+++ .++.|+++||+|+++|||||||||||||+|||||+|+||||+|+||++|||++||+.|+++|+++|++.+.+
T Consensus 181 VlP~~~~~~~~~i~~~dl~~~~~rssG~GGQ~VNkt~saVrl~H~ptgi~v~~q~eRSQ~~Nk~~A~~~L~~kL~~~~~~ 260 (325)
T PRK05589 181 VLPELTDDQDIEIRSEDLKIDTYRAGGAGGQHVNKTESAVRITHIPTGIVVQCQNERSQHSNKETAMKMLKSKLVELKER 260 (325)
T ss_pred EecCcCccccccCCchheEEEEeeCCCCCCCcccceeeEEEEEECCCCEEEEECCccCHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999865 588999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhHhhcccccCCCCCceeEeec-CCCceeeccccceecCcccccCCcChHHHHHHHHHH
Q 021200 240 RIHLSRSKLRSEQIGSGDRSERIRTYNF-PQGRVTDHRVGITHHAISDMMEGENLDIFIDALLLQ 303 (316)
Q Consensus 240 ~~~~~~~~~r~~~~~~~~rse~IRtYnf-~~~rVtDhR~~~~~~~l~~vl~G~~ld~~i~~l~~~ 303 (316)
+..++.++.| .+++..+||++|||||| ||+||||||||++++||+.||+| +||+||++++.+
T Consensus 261 ~~~~~~~~~r-~~~~~~~~g~~IRtY~~~p~~rVtDhR~g~~~~~l~~vl~G-~Ld~~I~a~l~~ 323 (325)
T PRK05589 261 AHKEKIEDLT-GELKDMGWGSQIRSYVFHPYNLVKDHRTGVETSNVDSVMDG-DIDNFITQYLKG 323 (325)
T ss_pred HHHHHHHHHh-cccccccccCCceeeECCCCceeeeeccCceecChHHhhCC-CHHHHHHHHHhh
Confidence 8888888866 45566789999999999 99999999999999999999999 699999999876
No 6
>PRK08787 peptide chain release factor 2; Provisional
Probab=100.00 E-value=1.7e-93 Score=679.21 Aligned_cols=296 Identities=34% Similarity=0.556 Sum_probs=274.0
Q ss_pred hHHHHHHHHHHHHHHHHHhHhhcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCeeEEEEcCCCcHHHH
Q 021200 2 HLISELRTKQKEIDGLKSLIYECSEDKDMLDMATEELCLAIDEEKRLQSLLLKSLLPKDDADERDCILEVRAGTGGEEAS 81 (316)
Q Consensus 2 ~~~~~~~~~~~el~el~~l~~e~~~D~em~e~a~eE~~~l~~~l~~le~~l~~~llp~~~~d~~~~~leI~aG~Gg~Ea~ 81 (316)
+.|+.+.....++.++.+|+.+ ++|++|++++.+|+..+..++++++- ..|| ++|+|.++|+|+|+||+||+||+
T Consensus 7 ~~~~~~~~~~~d~~~l~el~~~-~~d~e~~~~~~~e~~~l~~~~~~le~---~~lL-~~~~D~~~a~leI~aG~GG~Ea~ 81 (313)
T PRK08787 7 IGIADVLSGLADAGELLDLAES-EQDEDTALAVIADLDKYQAHVEKLEF---QRMF-SGQMDGANAFVDIQAGAGGTEAQ 81 (313)
T ss_pred HHHHHHHHHhhHHHHHHHHHHh-CCCHHHHHHHHHHHHHHHHHHHHHHH---HHHh-CCccccCCcEEEEECCCCcHHHH
Confidence 4566777777777777777766 57999999999999999999999873 3444 69999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHcCCeEEEEeeccCCCCCceEEEEEEeccccccceeeecceeEEEEeccccCCCCeeeceeEEEE
Q 021200 82 LFAVDVFKMYERYSQKKGWKFEVVGVTESDLRGYKEASAAISGVGVYGKLKFESGIHRVQRVPLTEKSGRVHTSAVSVAI 161 (316)
Q Consensus 82 ~~~~~L~~my~~~a~~~g~~~~~~~~~~~~~~g~~~~~~~i~G~~ay~~l~~E~GvHrv~rvp~~~~~gR~hts~~~V~v 161 (316)
+||++||+||.+||+++||++++++..+++.+||++|++.|+|++||++|++|+|||||||+|||+++||+||||++|+|
T Consensus 82 ~~a~~LlrMY~r~A~~~g~~~evi~~~~g~~~Giksa~l~I~G~~ayg~lk~E~GvHRv~R~sp~~s~~rrhTsfasV~V 161 (313)
T PRK08787 82 DWAEILLRMYLRWAESRGWKTELMEVSGGEVAGIKSATVRIEGEYAYGWLKTEIGVHRLVRKSPFDSDNRRHTSFTSVFV 161 (313)
T ss_pred HHHHHHHHHHHHHHHHcCCeEEEEecCCCCCceeeEEEEEEecccHHHHHhhccCeeEEEecCCCCCCCCEEeeeEEEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCc-cccccCCCCeEEEeeecCCCCCccccccCceEEEEeeCCceEEEEcCcCcHHHHHHHHHHHHHHHHHHHHHHH
Q 021200 162 LPQADE-VDVRLRNEDLRIDTYRSGGSGGQHANTTNSAVRVTHIPTGMTISIQDERSQHMNKAKALKVLCAKLYEMERSR 240 (316)
Q Consensus 162 lP~~~~-~~~~i~~~dl~~~~~RssGpGGQ~VNkt~saVrl~h~ptgi~v~~~~~RSq~~Nk~~A~~~L~~~L~~~~~~~ 240 (316)
+|.+++ +++.|+++||+|+|+|||||||||||||+|||||+|+||||+|+||++|||++||+.|+++|+++|++.+.++
T Consensus 162 ~P~~~~~~~i~i~~~dl~~~~~RssG~GGQ~VNkt~saVri~H~Ptgi~v~~q~eRSQ~~Nk~~A~~~L~~~L~~~~~e~ 241 (313)
T PRK08787 162 SPEVDDNIEIDINPADLRTDVYRSSGAGGQHVNKTESAVRITHIPTNTVVACQTGRSQHQNRDNAMKMLAAKLYELEVQK 241 (313)
T ss_pred ecCcCcccccccChhHeEEEEEECCCCCCCCcCCEeeEEEEEECCCcEEEEECCcccHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999865 6889999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred HHHHHhhHh--hcccccCCCCCceeEeecCCCceeeccccceecCcccccCCcChHHHHHHHHHHHHH
Q 021200 241 IHLSRSKLR--SEQIGSGDRSERIRTYNFPQGRVTDHRVGITHHAISDMMEGENLDIFIDALLLQQEM 306 (316)
Q Consensus 241 ~~~~~~~~r--~~~~~~~~rse~IRtYnf~~~rVtDhR~~~~~~~l~~vl~G~~ld~~i~~l~~~~~~ 306 (316)
+.++....| ++++ .||++||||||||+||||||||++++||++||+| +||+||++++.+...
T Consensus 242 ~~~~~~~~~~~k~~i---~~g~qIRtY~f~~~~V~DhRtg~~~~~l~~vldG-~ld~fI~a~l~~~~~ 305 (313)
T PRK08787 242 RNAEKDALEATKSDI---GWGSQIRNYVLDQSRIKDLRTGIERSDTQKVLDG-DLDEFVEASLKAGLA 305 (313)
T ss_pred HHHHHHHHhhhhhhC---cccccccceeCCCCcceeeccCceEcChhHhhCC-ChHHHHHHHHHHHHh
Confidence 888877765 5555 4777999999999999999999999999999999 699999999987543
No 7
>PRK07342 peptide chain release factor 2; Provisional
Probab=100.00 E-value=6.1e-93 Score=682.69 Aligned_cols=294 Identities=38% Similarity=0.595 Sum_probs=275.3
Q ss_pred hHHHHHHHHHHHHHHHHHhHhhcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCeeEEEEcCCCcHHHH
Q 021200 2 HLISELRTKQKEIDGLKSLIYECSEDKDMLDMATEELCLAIDEEKRLQSLLLKSLLPKDDADERDCILEVRAGTGGEEAS 81 (316)
Q Consensus 2 ~~~~~~~~~~~el~el~~l~~e~~~D~em~e~a~eE~~~l~~~l~~le~~l~~~llp~~~~d~~~~~leI~aG~Gg~Ea~ 81 (316)
+.|++|....+++.++.+|+.+ ++|++|+++|.+|+..+.++++.++ + ..|| .+|+|.++|+|+|+||+||+||+
T Consensus 30 ~~~~~~~~~~~~~~~l~el~~~-e~D~el~~~a~~e~~~l~~~l~~~e--l-~~lL-~~~~D~~~~~leI~aG~GG~Ea~ 104 (339)
T PRK07342 30 NGINHLEQTLNDNIELIAMGEE-EGDKSIVEDAEKTIRDLKDEIDRRQ--I-DALL-SGEADANDTYLEVHAGAGGTESQ 104 (339)
T ss_pred HHHHHHHHHHHHHHHHHHHHhc-cCCHHHHHHHHHHHHHHHHHHHHHH--H-HHHh-CCccccCCeeEEEECCCCcHHHH
Confidence 5788999999999999999865 4699999999999999999999864 3 3444 49999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHcCCeEEEEeeccCCCCCceEEEEEEeccccccceeeecceeEEEEeccccCCCCeeeceeEEEE
Q 021200 82 LFAVDVFKMYERYSQKKGWKFEVVGVTESDLRGYKEASAAISGVGVYGKLKFESGIHRVQRVPLTEKSGRVHTSAVSVAI 161 (316)
Q Consensus 82 ~~~~~L~~my~~~a~~~g~~~~~~~~~~~~~~g~~~~~~~i~G~~ay~~l~~E~GvHrv~rvp~~~~~gR~hts~~~V~v 161 (316)
+||++||+||.+||+++||++++++..+++.+||++|++.|+|++||++|++|+|||||||+|+|+++||+|||||+|+|
T Consensus 105 ~~a~~Ll~mY~~~a~~~g~~~~vi~~~~~~~~g~ksa~l~i~G~~ay~~lk~E~GvHrv~rvsp~~~~~rrhTs~a~V~V 184 (339)
T PRK07342 105 DWASMLLRMYTRWAERQGRKVEVLEVHDGEEAGIKSATILVKGHNAYGWLKTESGVHRLVRISPYDSNARRHTSFASIWV 184 (339)
T ss_pred HHHHHHHHHHHHHHHHcCCEEEEEecCCCCCCceEEEEEEEeccCHHHHHhhccceeEEEecCCCCCCCCeEeEEEEEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCc-cccccCCCCeEEEeeecCCCCCccccccCceEEEEeeCCceEEEEcCcCcHHHHHHHHHHHHHHHHHHHHHHH
Q 021200 162 LPQADE-VDVRLRNEDLRIDTYRSGGSGGQHANTTNSAVRVTHIPTGMTISIQDERSQHMNKAKALKVLCAKLYEMERSR 240 (316)
Q Consensus 162 lP~~~~-~~~~i~~~dl~~~~~RssGpGGQ~VNkt~saVrl~h~ptgi~v~~~~~RSq~~Nk~~A~~~L~~~L~~~~~~~ 240 (316)
+|.+++ +++.|+++||+|+++|||||||||||||+|||||+|+||||+|+|+++|||++||+.|+++|+++|++.+.++
T Consensus 185 lP~~~~~~~~~i~~~dl~~~~~RssG~GGQ~VNkt~saVrl~H~ptgi~v~~~~eRSQ~~Nk~~A~~~L~~~L~~~~~~~ 264 (339)
T PRK07342 185 YPVIDDNIEVDVNESDVRIDTYRSSGAGGQHVNTTDSAVRITHIPTGIVVQCQQERSQHKNRAKAWSMLRARLYEEELKK 264 (339)
T ss_pred EcCCCcccccccCcccEEEEEEECCCCCCCCccceeeeEEEEEcCCcEEEEECCcccHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999865 5889999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred HHHHHhhHh--hcccccCCCCCceeEeec-CCCceeeccccceecCcccccCCcChHHHHHHHHHHH
Q 021200 241 IHLSRSKLR--SEQIGSGDRSERIRTYNF-PQGRVTDHRVGITHHAISDMMEGENLDIFIDALLLQQ 304 (316)
Q Consensus 241 ~~~~~~~~r--~~~~~~~~rse~IRtYnf-~~~rVtDhR~~~~~~~l~~vl~G~~ld~~i~~l~~~~ 304 (316)
+.++.+..| +.++ .||++|||||| ||+||||||||++++||+.||+| +||+||++++.+.
T Consensus 265 ~~~~~~~~~~~~~~i---~~g~~IRtY~~~p~~rVtDhRtg~~~~~l~~vl~G-~Ld~~I~a~l~~~ 327 (339)
T PRK07342 265 REEATNAAAASKTDI---GWGHQIRSYVLQPYQLVKDLRTGVESTNPQDVLDG-DLNEFMEAALAHR 327 (339)
T ss_pred HHHHHHHHHhhhhhc---cccCCcCCccCCCCceeeeeccCceecChHHhhCC-CHHHHHHHHHHHH
Confidence 888887655 4444 57789999999 99999999999999999999999 6999999999874
No 8
>PRK00578 prfB peptide chain release factor 2; Validated
Probab=100.00 E-value=7.6e-93 Score=690.41 Aligned_cols=299 Identities=39% Similarity=0.619 Sum_probs=281.9
Q ss_pred ChHHHHHHHHHHHHHHHHHhHhhcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCeeEEEEcCCCcHHH
Q 021200 1 MHLISELRTKQKEIDGLKSLIYECSEDKDMLDMATEELCLAIDEEKRLQSLLLKSLLPKDDADERDCILEVRAGTGGEEA 80 (316)
Q Consensus 1 ~~~~~~~~~~~~el~el~~l~~e~~~D~em~e~a~eE~~~l~~~l~~le~~l~~~llp~~~~d~~~~~leI~aG~Gg~Ea 80 (316)
++.|++|+....+++++.+|+.+ +.|+||++||++|+..+.++++.++.+ .|| ++|+|.++|+|||+||+||+||
T Consensus 65 v~~~~~l~~~~~e~~~~~ell~~-e~D~el~~~a~~e~~~l~~~l~~le~~---~ll-~~~~D~~~~~leI~aG~GG~Ea 139 (367)
T PRK00578 65 LDTLEELRQRLDDLEELLELAEE-EDDEETLAEAEAELKALEKKLAALELE---RLL-SGEYDANNAILTIHAGAGGTEA 139 (367)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHHHHH---Hhc-CCCcccCCeEEEEecCCCcHHH
Confidence 35788999999999999999965 469999999999999999999999733 334 7999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHcCCeEEEEeeccCCCCCceEEEEEEeccccccceeeecceeEEEEeccccCCCCeeeceeEEE
Q 021200 81 SLFAVDVFKMYERYSQKKGWKFEVVGVTESDLRGYKEASAAISGVGVYGKLKFESGIHRVQRVPLTEKSGRVHTSAVSVA 160 (316)
Q Consensus 81 ~~~~~~L~~my~~~a~~~g~~~~~~~~~~~~~~g~~~~~~~i~G~~ay~~l~~E~GvHrv~rvp~~~~~gR~hts~~~V~ 160 (316)
++||++||+||.+||+.+||++++++..+++.+|+++|++.|+|++||++|++|+|||||||+|+|+++||+||||++|+
T Consensus 140 ~lfa~~L~~mY~~~a~~~g~~~evi~~~~~~~gg~ks~~~~i~G~~a~~~lk~E~GvHrvqrvs~~~~~~r~hts~~~V~ 219 (367)
T PRK00578 140 QDWASMLLRMYLRWAERHGFKVEVLDYSEGEEAGIKSATFKIKGPYAYGYLKSETGVHRLVRISPFDSAGRRHTSFASVE 219 (367)
T ss_pred HHHHHHHHHHHHHHHHHcCCEEEEEecCCCCCCCeeEEEEEEeccCHHHHHhhccceEEEEecCCCCCCCceecceeeEE
Confidence 99999999999999999999999999999998999999999999999999999999999999999999999999999999
Q ss_pred EecCCCc-cccccCCCCeEEEeeecCCCCCccccccCceEEEEeeCCceEEEEcCcCcHHHHHHHHHHHHHHHHHHHHHH
Q 021200 161 ILPQADE-VDVRLRNEDLRIDTYRSGGSGGQHANTTNSAVRVTHIPTGMTISIQDERSQHMNKAKALKVLCAKLYEMERS 239 (316)
Q Consensus 161 vlP~~~~-~~~~i~~~dl~~~~~RssGpGGQ~VNkt~saVrl~h~ptgi~v~~~~~RSq~~Nk~~A~~~L~~~L~~~~~~ 239 (316)
|+|.+++ .++.|+++||+|+|+|||||||||||||+|||||+|+||||+|+||++|||++||+.|+++|+++|++.+.+
T Consensus 220 vlP~~~~~~~~~i~~~dl~~~~~rssGpGGQ~vNkt~saVrl~h~ptgi~v~~~~~RSQ~~Nk~~A~~~L~~kL~~~~~~ 299 (367)
T PRK00578 220 VYPEVDDTIEIEINPKDLRIDTYRSSGAGGQHVNKTDSAVRITHIPTGIVVQCQNERSQHQNKASAMKMLKAKLYELELE 299 (367)
T ss_pred ecCCCCCccccccChhhEEEEEeeCCCCCCCcccceeeEEEEEECCCcEEEEECCCCCHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999875 478999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhHhhcccccCCCCCceeEeec-CCCceeeccccceecCcccccCCcChHHHHHHHHHHHHH
Q 021200 240 RIHLSRSKLRSEQIGSGDRSERIRTYNF-PQGRVTDHRVGITHHAISDMMEGENLDIFIDALLLQQEM 306 (316)
Q Consensus 240 ~~~~~~~~~r~~~~~~~~rse~IRtYnf-~~~rVtDhR~~~~~~~l~~vl~G~~ld~~i~~l~~~~~~ 306 (316)
++.+++++.|+.+ +..+||++|||||| ||+||||||||++++||+.||+| +||+||++|+.+...
T Consensus 300 ~~~~~~~~~r~~~-~~~~rg~~IRtYn~~p~~rVtDhR~g~~~~~l~~vl~G-~ld~~I~~l~~~~~~ 365 (367)
T PRK00578 300 KRAAEKDALKGEK-KEIGWGSQIRSYVLHPYQMVKDLRTGYETGNTQAVLDG-DLDGFIEAYLRWRAS 365 (367)
T ss_pred HHHHHHHHHHhhh-ccccccCCeEEEECCCCceeeeeccCceecCHHHhhCC-ChHHHHHHHHHHHhc
Confidence 9999999977665 67899999999999 99999999999999999999999 699999999887643
No 9
>TIGR00020 prfB peptide chain release factor 2. In many but not all taxa, there is a conserved real translational frameshift at a TGA codon. RF-2 helps terminate translation at TGA codons and can therefore regulate its own production by readthrough when RF-2 is insufficient. There is a Pfam model called "RF-1" for the superfamily of RF-1, RF-2, mitochondrial, RF-H, etc.
Probab=100.00 E-value=9.7e-93 Score=688.63 Aligned_cols=296 Identities=36% Similarity=0.612 Sum_probs=279.5
Q ss_pred ChHHHHHHHHHHHHHHHHHhHhhcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCeeEEEEcCCCcHHH
Q 021200 1 MHLISELRTKQKEIDGLKSLIYECSEDKDMLDMATEELCLAIDEEKRLQSLLLKSLLPKDDADERDCILEVRAGTGGEEA 80 (316)
Q Consensus 1 ~~~~~~~~~~~~el~el~~l~~e~~~D~em~e~a~eE~~~l~~~l~~le~~l~~~llp~~~~d~~~~~leI~aG~Gg~Ea 80 (316)
++.|++|....+++.++.+|+.+ +.|++|++||.+|+..+..+++.++.+ .+|++|+|.++|+|+|+||+||+||
T Consensus 65 v~~~~~~~~~~~d~~~l~el~~~-e~D~e~~~~a~~e~~~l~~~l~~le~~----~ll~~~~D~~~~~leI~aG~GG~Ea 139 (364)
T TIGR00020 65 LDTLEELKNSLEDLSELLELAVE-EDDEETFNELDAELKALEKKLAELELR----TMLSGEYDANNAYLTIQAGAGGTEA 139 (364)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHHHHH----hccCCCCccCCeeEEEECCCCcHHH
Confidence 35789999999999999999965 579999999999999999999998732 3468999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHcCCeEEEEeeccCCCCCceEEEEEEeccccccceeeecceeEEEEeccccCCCCeeeceeEEE
Q 021200 81 SLFAVDVFKMYERYSQKKGWKFEVVGVTESDLRGYKEASAAISGVGVYGKLKFESGIHRVQRVPLTEKSGRVHTSAVSVA 160 (316)
Q Consensus 81 ~~~~~~L~~my~~~a~~~g~~~~~~~~~~~~~~g~~~~~~~i~G~~ay~~l~~E~GvHrv~rvp~~~~~gR~hts~~~V~ 160 (316)
++||++||+||.+||+++||++++++..+++.+|+++|++.|+|++||++|++|+|||||||+|+|+++||+|||||+|+
T Consensus 140 ~~~a~~L~~mY~~~a~~~g~~~evi~~~~~~~~g~ks~~~~i~G~~ay~~lk~E~GvHrv~rvs~~~~~~rrhts~a~V~ 219 (364)
T TIGR00020 140 QDWASMLYRMYLRWAERRGFKVEIIDYSEGEEAGIKSVTILIKGPYAYGYLKSEQGVHRLVRISPFDANGRRHTSFASVF 219 (364)
T ss_pred HHHHHHHHHHHHHHHHHcCCEEEEEecCCCCCCceEEEEEEEeccCHHHHHhhccceEEEEecCCCCCCCCeEeeeEEEE
Confidence 99999999999999999999999999999998999999999999999999999999999999999999999999999999
Q ss_pred EecCC-CccccccCCCCeEEEeeecCCCCCccccccCceEEEEeeCCceEEEEcCcCcHHHHHHHHHHHHHHHHHHHHHH
Q 021200 161 ILPQA-DEVDVRLRNEDLRIDTYRSGGSGGQHANTTNSAVRVTHIPTGMTISIQDERSQHMNKAKALKVLCAKLYEMERS 239 (316)
Q Consensus 161 vlP~~-~~~~~~i~~~dl~~~~~RssGpGGQ~VNkt~saVrl~h~ptgi~v~~~~~RSq~~Nk~~A~~~L~~~L~~~~~~ 239 (316)
|+|.+ ++.++.|+++||+|+|+|||||||||||||+|||||+|+||||+|+||++|||++||+.|+++|+++|++.+.+
T Consensus 220 vlP~~~~~~~~~i~~~d~~~~~~rssG~GGQ~VNkt~saVri~H~ptgi~v~~q~~RSQ~~Nk~~A~~~L~~kL~~~~~~ 299 (364)
T TIGR00020 220 VMPEVDDDIDIEIKPEDLRIDTYRASGAGGQHVNKTDSAVRITHIPTGIVVQCQNDRSQHKNKDSAMKVLKAKLYELEME 299 (364)
T ss_pred EecCCCcccceecccccEEEEEeeCCCCCCccccccceEEEEEECCCcEEEEECCccCHHHHHHHHHHHHHHHHHHHHHH
Confidence 99998 46789999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhHhhcccccCCCCCceeEeec-CCCceeeccccceecCcccccCCcChHHHHHHHHHH
Q 021200 240 RIHLSRSKLRSEQIGSGDRSERIRTYNF-PQGRVTDHRVGITHHAISDMMEGENLDIFIDALLLQ 303 (316)
Q Consensus 240 ~~~~~~~~~r~~~~~~~~rse~IRtYnf-~~~rVtDhR~~~~~~~l~~vl~G~~ld~~i~~l~~~ 303 (316)
++.++++..|.++. ..+||++|||||| ||+||||||||++++||+.||+| +||+||++++.+
T Consensus 300 ~~~~~~~~~r~~~~-~~~rg~~IRtY~~~~~~rVtDhR~g~~~~~l~~vl~G-~Ld~~I~a~~~~ 362 (364)
T TIGR00020 300 KEQAEKDAKEGEKS-EIGWGSQIRSYVLHPYSMVKDLRTGYETGNVQAVLDG-DIDQFIEAYLKW 362 (364)
T ss_pred HHHHHHHHHHhhhh-ccCccCCeEEEECCCCCcccccccCCeecChHHHhCC-ChHHHHHHHHhh
Confidence 99999888775544 4589999999999 88999999999999999999999 699999999876
No 10
>KOG2726 consensus Mitochondrial polypeptide chain release factor [Translation, ribosomal structure and biogenesis]
Probab=100.00 E-value=6.9e-91 Score=671.65 Aligned_cols=309 Identities=49% Similarity=0.748 Sum_probs=298.0
Q ss_pred HHHHHHHHHHHHHHHHHhHhhcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCeeEEEEcCCCcHHHHH
Q 021200 3 LISELRTKQKEIDGLKSLIYECSEDKDMLDMATEELCLAIDEEKRLQSLLLKSLLPKDDADERDCILEVRAGTGGEEASL 82 (316)
Q Consensus 3 ~~~~~~~~~~el~el~~l~~e~~~D~em~e~a~eE~~~l~~~l~~le~~l~~~llp~~~~d~~~~~leI~aG~Gg~Ea~~ 82 (316)
.+.....+..++..++.|..+ .+|++|+++|.+|...+.+++..+..++...|||++|+|..+|+|||+||+||+||++
T Consensus 75 ~l~~~~~~~~~~~~lk~l~~~-~e~e~~~~~a~~E~~~~~~~i~~~~~~l~~~lLp~~~~D~~~~iiev~aGaGG~Ea~i 153 (386)
T KOG2726|consen 75 ALSDRMKLVRELKSLKSLIKE-GEDEDMDELAEEEAEEISKEIERSLHELELSLLPSDPYDAEACIIEVRAGAGGQEAQI 153 (386)
T ss_pred HHHHHHHHHHHhhhHHHHHhh-cccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCcccccCeEEEEeCCCCcHHHHH
Confidence 345556666777777888887 7899999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHcCCeEEEEeeccCCCCCceEEEEEEeccccccceeeecceeEEEEeccccCCCCeeeceeEEEEe
Q 021200 83 FAVDVFKMYERYSQKKGWKFEVVGVTESDLRGYKEASAAISGVGVYGKLKFESGIHRVQRVPLTEKSGRVHTSAVSVAIL 162 (316)
Q Consensus 83 ~~~~L~~my~~~a~~~g~~~~~~~~~~~~~~g~~~~~~~i~G~~ay~~l~~E~GvHrv~rvp~~~~~gR~hts~~~V~vl 162 (316)
|+.+|++||.+||+.+||++++++..+++.+||++|++.|+|.+||++|++|.|||||||+|.+++.||+|||+++|+|+
T Consensus 154 ft~el~~MY~~~a~~~~w~~~~l~~~~~~~~Gi~~At~~i~G~~ayg~l~~E~GvHRv~r~p~~e~~gr~htstasV~Vi 233 (386)
T KOG2726|consen 154 FTMELVDMYQKYAERLGWKARVLEKAPGESGGIKSATLEIEGESAYGYLKFEAGVHRVQRVPSTETSGRRHTSTASVAVI 233 (386)
T ss_pred HHHHHHHHHHHHHHhcccceeehhcCCcccccceeeeeEecccchhheeeccCcccceeecCCcccccccccccceEEEe
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCC--CccccccCCCCeEEEeeecCCCCCccccccCceEEEEeeCCceEEEEcCcCcHHHHHHHHHHHHHHHHHHHHHHH
Q 021200 163 PQA--DEVDVRLRNEDLRIDTYRSGGSGGQHANTTNSAVRVTHIPTGMTISIQDERSQHMNKAKALKVLCAKLYEMERSR 240 (316)
Q Consensus 163 P~~--~~~~~~i~~~dl~~~~~RssGpGGQ~VNkt~saVrl~h~ptgi~v~~~~~RSq~~Nk~~A~~~L~~~L~~~~~~~ 240 (316)
|.+ ++.++.|+++||+|+++|||||||||||||+|||||+|+||||+|+||++||||+||+.|+.+|+++|+..+.++
T Consensus 234 P~~~~~~~~~~~~~~dl~i~~~R~~G~GGQhvNktdsaVrl~HiPTGIvv~cq~eRSq~~Nr~~A~~~L~akL~~~~~~~ 313 (386)
T KOG2726|consen 234 PQPGRDEVDVEIDEKDLRIETFRASGPGGQHVNKTDSAVRLTHIPTGIVVECQEERSQHKNRALALKRLRAKLAVIYREE 313 (386)
T ss_pred ccCCCCccceecCchheeEEecccCCCCcccccccccceEEEeecCceEEEeecHHhHHhhHHHHHHHHHHHHHHHHHhh
Confidence 998 788999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhHhhcccccCCCCCceeEeecCCCceeeccccceecCcccccCCcChHHHHHHHHHHHHHHHHHccc
Q 021200 241 IHLSRSKLRSEQIGSGDRSERIRTYNFPQGRVTDHRVGITHHAISDMMEGENLDIFIDALLLQQEMDAIASFG 313 (316)
Q Consensus 241 ~~~~~~~~r~~~~~~~~rse~IRtYnf~~~rVtDhR~~~~~~~l~~vl~G~~ld~~i~~l~~~~~~~~~~~~~ 313 (316)
...+..+.|+.|+++++|+++||||||+|+||||||++++.+++.+||+| +||+||++++.+..++.+.++.
T Consensus 314 ~~~~~~~~r~~qv~s~~rsekiRTy~~~q~rv~D~r~~~~~~d~~~~l~G-~Ld~li~~~~~~~~~~~~~e~~ 385 (386)
T KOG2726|consen 314 KSEEEKKKRKAQVGSLKRSEKIRTYNFKQDRVTDHRIGLESHDLESFLDG-NLDELIEALLSLRREEDLAELL 385 (386)
T ss_pred hhHHhhhhhHHhhcccCchhceeecccCccchhhhhhcccccchHHHHhc-cHHHHHHHHHHHhhHHHHHHhh
Confidence 99999999999999999999999999999999999999999999999999 8999999999999999998764
No 11
>COG1186 PrfB Protein chain release factor B [Translation, ribosomal structure and biogenesis]
Probab=100.00 E-value=1.5e-72 Score=516.98 Aligned_cols=235 Identities=40% Similarity=0.670 Sum_probs=223.9
Q ss_pred eeEEEEcCCCcHHHHHHHHHHHHHHHHHHHHcCCeEEEEeeccCCCCCceEEEEEEeccccccceeeecceeEEEEeccc
Q 021200 67 CILEVRAGTGGEEASLFAVDVFKMYERYSQKKGWKFEVVGVTESDLRGYKEASAAISGVGVYGKLKFESGIHRVQRVPLT 146 (316)
Q Consensus 67 ~~leI~aG~Gg~Ea~~~~~~L~~my~~~a~~~g~~~~~~~~~~~~~~g~~~~~~~i~G~~ay~~l~~E~GvHrv~rvp~~ 146 (316)
|+|+|+||+||+|||+||.+||+||++||+++||++++++..+|+.+|+||++|.|+|++|||+|+.|.||||++|++|+
T Consensus 1 ~~l~i~~g~gg~e~~dw~~~l~rmy~r~a~~~g~~~e~l~~~~g~~~g~ks~~~~~~g~~a~g~~~~e~g~hrlvr~Spf 80 (239)
T COG1186 1 AYLTIHAGAGGTEAQDWASMLLRMYTRWAERKGFKVEVLDTSDGEEAGIKSATLKIKGENAYGYLKTETGVHRLVRISPF 80 (239)
T ss_pred CEEEEeCCCCchHHHHHHHHHHHHHHHHHHHcCCeEEEEeccCCcccccceEEEEEechHHHHHHHhhcceeEEEeecCC
Confidence 78999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCeeeceeEEEEecCCC-ccccccCCCCeEEEeeecCCCCCccccccCceEEEEeeCCceEEEEcCcCcHHHHHHHH
Q 021200 147 EKSGRVHTSAVSVAILPQAD-EVDVRLRNEDLRIDTYRSGGSGGQHANTTNSAVRVTHIPTGMTISIQDERSQHMNKAKA 225 (316)
Q Consensus 147 ~~~gR~hts~~~V~vlP~~~-~~~~~i~~~dl~~~~~RssGpGGQ~VNkt~saVrl~h~ptgi~v~~~~~RSq~~Nk~~A 225 (316)
.+.+|+||||++|.|+|..+ .+++.|++.||+|+|+|||||||||||||+|||||||+||||+|.||.+||||+|++.|
T Consensus 81 ~~~~~R~tsf~~v~v~p~~~~~i~i~I~~~dl~idt~RASGaGGQhVNKt~SAVrlth~ptgivv~cq~eRSq~~n~~~a 160 (239)
T COG1186 81 DSNGRRHTSFASVEVFPELDISIEIEIPDDDLRIDTYRASGAGGQHVNKTDSAVRLTHLPTGIVVLCQNERSQHLNKALA 160 (239)
T ss_pred CcCcccccceeeeeecCCCCcccceecCccceEEEEEEcCCCCCCccccccccEEEEEcCCCCEecCHHHHHHHHHHHHH
Confidence 99999999999999999985 56889999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhHhhcccccCCCCCceeEeec-CCCceeeccccceecCcccccCCcChHHHHHHHHHH
Q 021200 226 LKVLCAKLYEMERSRIHLSRSKLRSEQIGSGDRSERIRTYNF-PQGRVTDHRVGITHHAISDMMEGENLDIFIDALLLQ 303 (316)
Q Consensus 226 ~~~L~~~L~~~~~~~~~~~~~~~r~~~~~~~~rse~IRtYnf-~~~rVtDhR~~~~~~~l~~vl~G~~ld~~i~~l~~~ 303 (316)
+..|+.+|+....+++.++++..+..+. ...|+.+||+|.| |+..|+|||++++..+.+.+|+| ++|.||++.+.+
T Consensus 161 ~~~l~~kL~~~~~~~Rsqe~n~~~a~~k-~i~wg~qirsyv~~p~~~vKd~Rt~~E~~~~~~v~dg-~~~~~~~~~l~~ 237 (239)
T COG1186 161 RKMLKGKLYILAQEKRSQEKNRERALKK-LIGWGNQIRSYVLDPYQPTKDLRTGVERRNKSKVLDG-DKDGFIKAYLKW 237 (239)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhh-hHHHHHhccccCCCccccccccccceeeccHHHhhhh-hHHHHHHhhhhc
Confidence 9999999999999999999888665442 3578889999999 58899999999999999999999 899999987765
No 12
>TIGR03072 release_prfH putative peptide chain release factor H. Members of this protein family are bacterial proteins homologous to peptide chain release factors 1 (RF-1, product of the prfA gene), and 2 (RF-2, product of the prfB gene). The member from Escherichia coli K-12, designated prfH, appears to be a pseudogene. This class I release factor is always found as the downstream gene of a two-gene operon.
Probab=100.00 E-value=3.2e-66 Score=467.29 Aligned_cols=197 Identities=23% Similarity=0.337 Sum_probs=177.2
Q ss_pred eeEEEEcCCCcHHHHHHHHHHHHHHHHHHHHcCCeEEEEeeccCCC-CCceEEEEEEeccccccceeeecceeEEEEecc
Q 021200 67 CILEVRAGTGGEEASLFAVDVFKMYERYSQKKGWKFEVVGVTESDL-RGYKEASAAISGVGVYGKLKFESGIHRVQRVPL 145 (316)
Q Consensus 67 ~~leI~aG~Gg~Ea~~~~~~L~~my~~~a~~~g~~~~~~~~~~~~~-~g~~~~~~~i~G~~ay~~l~~E~GvHrv~rvp~ 145 (316)
++|||+||+||+||++||++||+||.+||+++||++++++..+++. +|+++|+|.|+|++||++|+.|.|+|++++.|+
T Consensus 1 ~~leI~aG~GG~Ea~lfa~~L~~my~~~a~~~g~~~eii~~~~~~~~gg~ksa~~~i~G~~ay~~l~~~~G~h~~v~~sp 80 (200)
T TIGR03072 1 ILLQLSSAQGPAECCLAVAKALERLTREAAARGVRVEVLEQEPGEVPGTLRSALVSLDGEAAAALADRWEGTLLWICPSP 80 (200)
T ss_pred CEEEEECCCCcHHHHHHHHHHHHHHHHHHHHcCCeEEEEeCCCCCCCCceEEEEEEEEccCHHHHhhcccceEEEEEcCC
Confidence 4899999999999999999999999999999999999999999886 569999999999999999977766665544444
Q ss_pred ccCCCCeeeceeEEEEecCCCccccccCCCCeEEEeeecCCCCCccccccCceEEEEeeCCceEEEEcCcCcHHHHHHHH
Q 021200 146 TEKSGRVHTSAVSVAILPQADEVDVRLRNEDLRIDTYRSGGSGGQHANTTNSAVRVTHIPTGMTISIQDERSQHMNKAKA 225 (316)
Q Consensus 146 ~~~~gR~hts~~~V~vlP~~~~~~~~i~~~dl~~~~~RssGpGGQ~VNkt~saVrl~h~ptgi~v~~~~~RSq~~Nk~~A 225 (316)
+..++++||||++|.|+|. ++.|+++||+++|+|||||||||||||+|||||+|+||||+|+||++|||++||+.|
T Consensus 81 ~r~~~~R~ts~~~V~v~~~----~~~i~~~dl~~~~~RssGpGGQ~vNkt~saVrl~h~ptgi~v~~~~~RSQ~~Nk~~A 156 (200)
T TIGR03072 81 YRPHHRRKNWFIGVQRFSA----SEEATEDEIRFETLRSSGPGGQHVNKTESAVRATHLASGISVKVQSERSQHANKRLA 156 (200)
T ss_pred CCCCCCeeEEEEEEEEecC----ccccChhheEEEEEECCCCCcccccccceeEEEEECCCcEEEEECCccCHHHHHHHH
Confidence 4445666699999999984 456899999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhHhhcccccCCCCCceeEeecC
Q 021200 226 LKVLCAKLYEMERSRIHLSRSKLRSEQIGSGDRSERIRTYNFP 268 (316)
Q Consensus 226 ~~~L~~~L~~~~~~~~~~~~~~~r~~~~~~~~rse~IRtYnf~ 268 (316)
+++|+++|++.+.+++.++.+ .|+.++.+.+||+|||||||+
T Consensus 157 ~~~L~~~l~~~~~~~~~~~~~-~~r~~~~~~~Rg~~iRty~~~ 198 (200)
T TIGR03072 157 TLLLAVRLADLQQEQAAALRA-ERRTAHHQIERGNPVRVFKGE 198 (200)
T ss_pred HHHHHHHHHHHHHHHHHHHHH-HHHhccccccccCceEeeeCC
Confidence 999999999999888755554 477778889999999999986
No 13
>PRK08179 prfH peptide chain release factor-like protein; Reviewed
Probab=100.00 E-value=4.4e-65 Score=459.90 Aligned_cols=195 Identities=24% Similarity=0.345 Sum_probs=175.8
Q ss_pred eeEEEEcCCCcHHHHHHHHHHHHHHHHHHHHcCCeEEEEeeccCCC-CCceEEEEEEeccccccceeee-cceeEEEEec
Q 021200 67 CILEVRAGTGGEEASLFAVDVFKMYERYSQKKGWKFEVVGVTESDL-RGYKEASAAISGVGVYGKLKFE-SGIHRVQRVP 144 (316)
Q Consensus 67 ~~leI~aG~Gg~Ea~~~~~~L~~my~~~a~~~g~~~~~~~~~~~~~-~g~~~~~~~i~G~~ay~~l~~E-~GvHrv~rvp 144 (316)
++|||+||+||+||++||++||+||.+||+++||++++++..+++. +|+++|++.|+|++||++|+.| +|+|||+++|
T Consensus 2 ~~leI~aG~Gg~Ea~~fa~~L~~my~~~a~~~g~~~~ii~~~~~~~~gg~ksa~~~i~G~~a~~~l~~~~G~~~~V~~sp 81 (200)
T PRK08179 2 ILLQLSSAQGPAECCLAVAKALERLLKEAARQGVRVTVLETETGRYPDTLRSALVSLDGDNAEALAESWCGTIQWICPSP 81 (200)
T ss_pred EEEEEeCCCChHHHHHHHHHHHHHHHHHHHHcCCeEEEEeCCCCCCCCceEEEEEEEEccCHHHHhhcccCeeEEEecCC
Confidence 6899999999999999999999999999999999999999999987 5699999999999999999955 5555556666
Q ss_pred cccCCCCeeeceeEEEEecCCCccccccCCCCeEEEeeecCCCCCccccccCceEEEEeeCCceEEEEcCcCcHHHHHHH
Q 021200 145 LTEKSGRVHTSAVSVAILPQADEVDVRLRNEDLRIDTYRSGGSGGQHANTTNSAVRVTHIPTGMTISIQDERSQHMNKAK 224 (316)
Q Consensus 145 ~~~~~gR~hts~~~V~vlP~~~~~~~~i~~~dl~~~~~RssGpGGQ~VNkt~saVrl~h~ptgi~v~~~~~RSq~~Nk~~ 224 (316)
+++.++ +||||++|+|+|. ++.|+++||+++|+|||||||||||||+|||||+|+||||+|+||++|||++||+.
T Consensus 82 ~~~~~~-R~~s~~~V~v~~~----~~~i~~~dl~~~~~RssGpGGQ~VNkt~saVrl~h~ptgi~v~~~~~RSQ~~Nk~~ 156 (200)
T PRK08179 82 YRPHHG-RKNWFVGIGRFSA----DEEEQSDEIRFETLRSSGPGGQHVNKTDSAVRATHLASGISVKVQSERSQHANKRL 156 (200)
T ss_pred CCCCCC-ceEEEEEEEEeCC----cCccCHHHeEEEEEEccCCcccccccccceEEEEEcCCcEEEEECCCCCHHHHHHH
Confidence 666555 4567999999976 34789999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhHhhcccccCCCCCceeEeec
Q 021200 225 ALKVLCAKLYEMERSRIHLSRSKLRSEQIGSGDRSERIRTYNF 267 (316)
Q Consensus 225 A~~~L~~~L~~~~~~~~~~~~~~~r~~~~~~~~rse~IRtYnf 267 (316)
|+++|+++|++.+.+++.++++. |+.++++.+||+|||||.-
T Consensus 157 A~~~L~~~L~~~~~~~~~~~~~~-~~~~~~~~~Rg~~IRt~~~ 198 (200)
T PRK08179 157 ARLLIAWKLEQQQQEQSAALKSQ-RRMFHHQIERGNPRRVFTG 198 (200)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHH-HHhccccccccCceEeeec
Confidence 99999999999998877666555 7777888999999999964
No 14
>PF00472 RF-1: RF-1 domain; InterPro: IPR000352 Peptide chain release factors (RFs) are required for the termination of protein biosynthesis []. At present two classes of RFs can be distinguished. Class I RFs bind to ribosomes that have encountered a stop codon at their decoding site and induce release of the nascent polypeptide. Class II RFs are GTP-binding proteins that interact with class I RFs and enhance class I RF activity. In prokaryotes there are two class I RFs that act in a codon specific manner []: RF-1 (gene prfA) mediates UAA and UAG-dependent termination while RF-2 (gene prfB) mediates UAA and UGA-dependent termination. RF-1 and RF-2 are structurally and evolutionary related proteins which have been shown to be part of a larger family [].; GO: 0003747 translation release factor activity, 0006415 translational termination; PDB: 2JY9_A 1ZBT_A 1GQE_A 3F1G_X 3F1E_X 1RQ0_C 4DH9_Y 2JVA_A 1J26_A 3D5A_X ....
Probab=100.00 E-value=2.8e-38 Score=262.66 Aligned_cols=110 Identities=45% Similarity=0.700 Sum_probs=104.0
Q ss_pred ccccccCCCCeEEEeeecCCCCCccccccCceEEEEeeCCceEEEEcCcCcHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 021200 167 EVDVRLRNEDLRIDTYRSGGSGGQHANTTNSAVRVTHIPTGMTISIQDERSQHMNKAKALKVLCAKLYEMERSRIHLSRS 246 (316)
Q Consensus 167 ~~~~~i~~~dl~~~~~RssGpGGQ~VNkt~saVrl~h~ptgi~v~~~~~RSq~~Nk~~A~~~L~~~L~~~~~~~~~~~~~ 246 (316)
..++.|+++||+++|+|||||||||||||+|+|+|+|+||||+|+|+++|||++|++.|+++|+++|.++..++......
T Consensus 4 ~~~~~i~~~dl~~~~~RssGpGGQ~VNk~~s~V~l~h~ptgi~v~~~~~Rsq~~Nr~~A~~~L~~~l~~~~~~~~~~~~~ 83 (113)
T PF00472_consen 4 EKEIDIPEKDLEISFSRSSGPGGQNVNKTNSKVRLRHIPTGIVVKCQESRSQHQNREDALEKLREKLDEAYREKRREKTR 83 (113)
T ss_dssp SSSSCC-GGGEEEEEEESSSSSSCHHHSSSEEEEEEETTTTEEEEEESSSSHHHHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccccCHHHeEEEEEecCCCCCCcccccCCEEEEEEecccEEEEEcccCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 35678999999999999999999999999999999999999999999999999999999999999999999888888888
Q ss_pred hHhhcccccCCCCCceeEeecCCCceeecc
Q 021200 247 KLRSEQIGSGDRSERIRTYNFPQGRVTDHR 276 (316)
Q Consensus 247 ~~r~~~~~~~~rse~IRtYnf~~~rVtDhR 276 (316)
..|+++....+|+++||+|+||+++|||||
T Consensus 84 ~~~~~~~~~~~~~~~iR~y~~~~~~vk~~R 113 (113)
T PF00472_consen 84 EIRKSQVKRLERKKKIRTYNFPRSRVKDHR 113 (113)
T ss_dssp TTTTTSCCCSSTTSEEEEEETTTTEEEETT
T ss_pred HHHHHHHhHHhhhcceecccCChhhcccCC
Confidence 888898888999999999999999999998
No 15
>PF03462 PCRF: PCRF domain; InterPro: IPR005139 This domain is found in peptide chain release factors. Peptide chain release factors are important for protein synthesis since they direct the termination of translation in response to the peptide chain termination codons UAG and UAA. These are structurally distinct but both contain the PCRF domain [].; GO: 0016149 translation release factor activity, codon specific, 0006415 translational termination, 0005737 cytoplasm; PDB: 3D5A_X 3D5C_X 3MR8_V 3MS0_V 3F1G_X 3F1E_X 1ZBT_A 2IHR_1 2X9R_Y 2X9T_Y ....
Probab=100.00 E-value=9.5e-33 Score=229.98 Aligned_cols=112 Identities=47% Similarity=0.808 Sum_probs=105.2
Q ss_pred hcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCCCCCCccCCeeEEEEcCCCcHHHHHHHHHHHHHHHHHHHHcCCeE
Q 021200 23 ECSEDKDMLDMATEELCLAIDEEKRLQSLLLKSLLPKDDADERDCILEVRAGTGGEEASLFAVDVFKMYERYSQKKGWKF 102 (316)
Q Consensus 23 e~~~D~em~e~a~eE~~~l~~~l~~le~~l~~~llp~~~~d~~~~~leI~aG~Gg~Ea~~~~~~L~~my~~~a~~~g~~~ 102 (316)
+.++|+||+++|++|+..+.++++.++.++...|+|++++|.++|+|||+||+||+||++||.+|++||.+||+++||++
T Consensus 4 ~~~~D~e~~~~~~~e~~~~~~~l~~l~~~l~~~ll~~~~~d~~~~ileI~aG~GG~EA~lfa~~L~~MY~~~a~~~gw~~ 83 (115)
T PF03462_consen 4 EEEEDEEMRELAEEEIEQLEEELEELEKELLDSLLPSDPYDANNAILEIRAGAGGDEACLFAEELFRMYQRYAERRGWKV 83 (115)
T ss_dssp CCCT-HHHHHHHHHHHHHHHHHHHHHHHHHHHHHCHHSSTTTSEEEEEEEE-SSTHHHHHHHHHHHHHHHHHHHHTT-EE
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCcccccCeEEEEecCCCchHHHHHHHHHHHHHHHHHHHcCCEE
Confidence 34789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEeeccCCCCCceEEEEEEeccccccceeee
Q 021200 103 EVVGVTESDLRGYKEASAAISGVGVYGKLKFE 134 (316)
Q Consensus 103 ~~~~~~~~~~~g~~~~~~~i~G~~ay~~l~~E 134 (316)
++++..+++.+|+++|++.|+|++||++|++|
T Consensus 84 ~~l~~~~~~~~G~k~a~~~I~G~~aY~~Lk~E 115 (115)
T PF03462_consen 84 EVLDYSPGEEGGIKSATLEISGEGAYGYLKFE 115 (115)
T ss_dssp EEEEEEE-SSSSEEEEEEEEESTTHHHHHGGG
T ss_pred EEEecCCCCccceeEEEEEEEcCChHHhccCC
Confidence 99999999999999999999999999999987
No 16
>PRK09256 hypothetical protein; Provisional
Probab=99.87 E-value=1.1e-22 Score=174.67 Aligned_cols=70 Identities=31% Similarity=0.491 Sum_probs=64.8
Q ss_pred ccccCCCCeEEEeeecCCCCCccccccCceEEEEe------eC-----------------Cc-eEEEEcCcCcHHHHHHH
Q 021200 169 DVRLRNEDLRIDTYRSGGSGGQHANTTNSAVRVTH------IP-----------------TG-MTISIQDERSQHMNKAK 224 (316)
Q Consensus 169 ~~~i~~~dl~~~~~RssGpGGQ~VNkt~saVrl~h------~p-----------------tg-i~v~~~~~RSq~~Nk~~ 224 (316)
++.|++.||++.|+|||||||||||||+|+|+|+| +| +| |+|+|+++|||++|++.
T Consensus 7 ~~~i~~~~l~~~~~RSSGPGGQ~VNKt~SkV~l~~~~~~~~lp~~~~~~l~~~~~~r~~~~g~l~i~~~~~RSQ~~Nr~~ 86 (138)
T PRK09256 7 RLVIPENELEWRFIRASGPGGQNVNKVSTAVELRFDIAASSLPEFYKERLLALAGHRITKDGVIVIKAQEFRSQERNRED 86 (138)
T ss_pred cCccCHHHeEEEEEEcCCCCcccccccceeeEEEechhhccCCHHHHHHHHHHhcCcccCCCcEEEEECCcCCHHHHHHH
Confidence 56789999999999999999999999999999996 77 35 99999999999999999
Q ss_pred HHHHHHHHHHHHHH
Q 021200 225 ALKVLCAKLYEMER 238 (316)
Q Consensus 225 A~~~L~~~L~~~~~ 238 (316)
|+++|.++|.++..
T Consensus 87 al~kL~~~i~~~~~ 100 (138)
T PRK09256 87 ALERLVALIREALK 100 (138)
T ss_pred HHHHHHHHHHHHhh
Confidence 99999999998764
No 17
>KOG3429 consensus Predicted peptidyl-tRNA hydrolase [Translation, ribosomal structure and biogenesis]
Probab=99.62 E-value=6.6e-16 Score=134.90 Aligned_cols=71 Identities=34% Similarity=0.454 Sum_probs=62.7
Q ss_pred cccccCCCCeEEEeeecCCCCCccccccCceEEEEe-------eC------------------CceEEEEcCcCcHHHHH
Q 021200 168 VDVRLRNEDLRIDTYRSGGSGGQHANTTNSAVRVTH-------IP------------------TGMTISIQDERSQHMNK 222 (316)
Q Consensus 168 ~~~~i~~~dl~~~~~RssGpGGQ~VNkt~saVrl~h-------~p------------------tgi~v~~~~~RSq~~Nk 222 (316)
.+-.||...+.+.|.||||||||||||++|+|.+++ || .-|++.++.+||||.|.
T Consensus 33 ~~g~ipld~~~i~y~RSSGPGGQNVNKvNTKv~vrf~vs~a~Wipe~~R~~~~~~~~~rink~gelvI~Sd~TRsq~~Ni 112 (172)
T KOG3429|consen 33 FKGKIPLDQLEISYSRSSGPGGQNVNKVNTKVEVRFKVSNAEWIPEFLRNKLLTTEKNRINKDGELVIYSDKTRSQHKNI 112 (172)
T ss_pred cCCCCchhheEEEEeecCCCCCcccccccceEEEEEecchhhhccHHHHHHHHHHHHHhhccCccEEEecchhHHhhccH
Confidence 345688889999999999999999999999999874 33 13999999999999999
Q ss_pred HHHHHHHHHHHHHHHH
Q 021200 223 AKALKVLCAKLYEMER 238 (316)
Q Consensus 223 ~~A~~~L~~~L~~~~~ 238 (316)
++||++|++.|++.+.
T Consensus 113 aDcleKlr~~I~~~~~ 128 (172)
T KOG3429|consen 113 ADCLEKLRDIIRAAEQ 128 (172)
T ss_pred HHHHHHHHHHHHHHhc
Confidence 9999999999988764
No 18
>PF04350 PilO: Pilus assembly protein, PilO; PDB: 2RJZ_B.
Probab=68.47 E-value=11 Score=31.35 Aligned_cols=43 Identities=16% Similarity=0.213 Sum_probs=26.6
Q ss_pred HHHHHHHHHHHHHHcCCeEEEEeeccCC-CCCce--EEEEEEeccc
Q 021200 84 AVDVFKMYERYSQKKGWKFEVVGVTESD-LRGYK--EASAAISGVG 126 (316)
Q Consensus 84 ~~~L~~my~~~a~~~g~~~~~~~~~~~~-~~g~~--~~~~~i~G~~ 126 (316)
...|+.-...+|...|.++.-+...+.. ..++. .+.+.+.|.+
T Consensus 52 ~~~ll~~l~~~A~~~gv~l~~~~p~~~~~~~~~~~~pv~i~l~G~Y 97 (144)
T PF04350_consen 52 IPSLLEDLNRLAKKSGVKLTSFEPGEEEKKEFYIEIPVTISLEGSY 97 (144)
T ss_dssp HHHHHHHHHHHHHHTT-EEEEEEE---EE-SSEEEEEEEEEEEEEH
T ss_pred HHHHHHHHHHHHHHCCCeEEEeecCcccccCceEEEEEEEEEEeeH
Confidence 4567777889999999998877655433 34555 4555666644
No 19
>PF09032 Siah-Interact_N: Siah interacting protein, N terminal ; InterPro: IPR015120 The N-terminal domain of Siah interacting protein (SIP) adopts a helical hairpin structure with a hydrophobic core stabilised by a classic knobs-and-holes arrangement of side chains contributed by the two amphipathic helices. Little is known about this domain's function, except that it is crucial for interactions with Siah. It has also been hypothesised that SIP can dimerise through this N-terminal domain []. ; PDB: 1YSM_A 2A26_C 2A25_B 1X5M_A.
Probab=66.73 E-value=18 Score=28.66 Aligned_cols=45 Identities=27% Similarity=0.378 Sum_probs=38.0
Q ss_pred HHHHHHHHHHHHHHHhHhhcCCCHHHHHHHHHHHHHHHHHHHHHHH
Q 021200 5 SELRTKQKEIDGLKSLIYECSEDKDMLDMATEELCLAIDEEKRLQS 50 (316)
Q Consensus 5 ~~~~~~~~el~el~~l~~e~~~D~em~e~a~eE~~~l~~~l~~le~ 50 (316)
+.+..+..||+|+..|+.. -.-+..++++..|+..++.++..+..
T Consensus 3 ~~i~eL~~Dl~El~~Ll~~-a~R~rVk~~L~~ei~klE~eI~~~~~ 47 (79)
T PF09032_consen 3 EQIEELQLDLEELKSLLEQ-AKRKRVKDLLTNEIRKLETEIKKLKE 47 (79)
T ss_dssp HHHHHHHHHHHHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHCHH
T ss_pred hHHHHHHHHHHHHHHHHHH-hhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3577889999999999865 35788999999999999999988764
No 20
>PF13710 ACT_5: ACT domain; PDB: 2FGC_A 2PC6_A 2F1F_B.
Probab=52.80 E-value=39 Score=24.99 Aligned_cols=38 Identities=16% Similarity=0.314 Sum_probs=30.1
Q ss_pred HHHHHHHHHHcCCeEEEEeeccCCCCCceEEEEEEecc
Q 021200 88 FKMYERYSQKKGWKFEVVGVTESDLRGYKEASAAISGV 125 (316)
Q Consensus 88 ~~my~~~a~~~g~~~~~~~~~~~~~~g~~~~~~~i~G~ 125 (316)
+.-....+.++||.++-+...+++..|+..+++.+.|+
T Consensus 6 L~Ri~~vf~rRg~nI~sl~v~~~~~~~~~riti~v~~~ 43 (63)
T PF13710_consen 6 LNRITGVFRRRGFNIESLSVGPTEDPGISRITIVVSGD 43 (63)
T ss_dssp HHHHHHHHHTTT-EECEEEEEE-SSTTEEEEEEEEES-
T ss_pred HHHHHHHHhcCCeEEeeEEeeecCCCCEEEEEEEEeeC
Confidence 44456677899999999999988889999999999994
No 21
>KOG3274 consensus Uncharacterized conserved protein, AMMECR1 [Function unknown]
Probab=49.96 E-value=14 Score=33.98 Aligned_cols=110 Identities=17% Similarity=0.257 Sum_probs=62.9
Q ss_pred HHHHHHHHHHcCCeEEEEeeccCCCCCceEEEEEEeccccccceeeecceeEEEEeccccCCCCeeeceeEEEEecCCCc
Q 021200 88 FKMYERYSQKKGWKFEVVGVTESDLRGYKEASAAISGVGVYGKLKFESGIHRVQRVPLTEKSGRVHTSAVSVAILPQADE 167 (316)
Q Consensus 88 ~~my~~~a~~~g~~~~~~~~~~~~~~g~~~~~~~i~G~~ay~~l~~E~GvHrv~rvp~~~~~gR~hts~~~V~vlP~~~~ 167 (316)
++-|..-+..+.=++..+...+-. .-.=+|.+.++-+.++++|-||.|+|-| |+-++...|.+-+++- +|+...
T Consensus 76 l~eYaltsAl~DsRF~PIsr~ELp-~L~CsvslL~nFE~i~d~lDWevG~HGI-rieF~~e~g~krsATy----LPeVa~ 149 (210)
T KOG3274|consen 76 LREYALTSALKDSRFPPISREELP-SLQCSVSLLTNFEDIFDYLDWEVGVHGI-RIEFTNETGTKRSATY----LPEVAA 149 (210)
T ss_pred HHHHHHHHHhhcccCCCCChhhcC-ceEEEEEeeccchhcccccceeeccceE-EEEEEcCCCcEeeeee----cccchh
Confidence 456666666666666666543221 1123777888889999999999999966 6888776676655432 666531
Q ss_pred cccccCCCCeEEEeeecCCCCCccccccCceEEEEee
Q 021200 168 VDVRLRNEDLRIDTYRSGGSGGQHANTTNSAVRVTHI 204 (316)
Q Consensus 168 ~~~~i~~~dl~~~~~RssGpGGQ~VNkt~saVrl~h~ 204 (316)
.. ..+.-+--=.-.|=+|=+|---+-...++++|--
T Consensus 150 EQ-gWd~~eTidsLirKaGY~g~It~~~r~~I~ltRY 185 (210)
T KOG3274|consen 150 EQ-GWDQIETIDSLIRKAGYKGPITEELRKSIKLTRY 185 (210)
T ss_pred hc-CCcHHHHHHHHHHhcCCCCccCHHHHhheeeeEe
Confidence 00 0000000001456566666443345556666643
No 22
>PRK06737 acetolactate synthase 1 regulatory subunit; Validated
Probab=43.75 E-value=65 Score=25.14 Aligned_cols=39 Identities=13% Similarity=0.187 Sum_probs=32.6
Q ss_pred HHHHHHHHHHcCCeEEEEeeccCCCCCceEEEEEEeccc
Q 021200 88 FKMYERYSQKKGWKFEVVGVTESDLRGYKEASAAISGVG 126 (316)
Q Consensus 88 ~~my~~~a~~~g~~~~~~~~~~~~~~g~~~~~~~i~G~~ 126 (316)
+.-....+.++||.++-+...+++..|+...++.+.|+.
T Consensus 16 L~Ri~~lf~rRgfNI~Sl~vg~te~~~~sriti~~~~~~ 54 (76)
T PRK06737 16 LLRISGIFARRGYYISSLNLNERDTSGVSEMKLTAVCTE 54 (76)
T ss_pred HHHHHHHHhccCcceEEEEecccCCCCeeEEEEEEECCH
Confidence 445566778899999999988888899999999988754
No 23
>PRK11152 ilvM acetolactate synthase 2 regulatory subunit; Provisional
Probab=37.52 E-value=67 Score=25.03 Aligned_cols=41 Identities=7% Similarity=0.094 Sum_probs=32.9
Q ss_pred HHHHHHHHHHcCCeEEEEeeccCCCCCceEEEEEEeccccc
Q 021200 88 FKMYERYSQKKGWKFEVVGVTESDLRGYKEASAAISGVGVY 128 (316)
Q Consensus 88 ~~my~~~a~~~g~~~~~~~~~~~~~~g~~~~~~~i~G~~ay 128 (316)
+.-....+.++||.++-++..+++..++..+++.+.++.+.
T Consensus 17 L~Ri~~lf~rRGfnI~sl~v~~t~~~~~sriti~v~~~~~i 57 (76)
T PRK11152 17 LERVLRVVRHRGFQVCSMNMTQNTDAQNINIELTVASERPI 57 (76)
T ss_pred HHHHHHHHhcCCeeeeeEEeeecCCCCEEEEEEEECCCchH
Confidence 34455677899999999999888888899999999765544
No 24
>PF15188 CCDC-167: Coiled-coil domain-containing protein 167
Probab=37.51 E-value=1.7e+02 Score=23.49 Aligned_cols=48 Identities=10% Similarity=0.050 Sum_probs=34.8
Q ss_pred HHHHHHHHHHHHHhHhhcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 021200 7 LRTKQKEIDGLKSLIYECSEDKDMLDMATEELCLAIDEEKRLQSLLLK 54 (316)
Q Consensus 7 ~~~~~~el~el~~l~~e~~~D~em~e~a~eE~~~l~~~l~~le~~l~~ 54 (316)
+.....+++.++.=+...+-.+|=++.+++|...+.+.+...+++|..
T Consensus 14 l~~cr~~le~ve~rL~~~eLs~e~R~~lE~E~~~l~~~l~~~E~eL~~ 61 (85)
T PF15188_consen 14 LAQCRRRLEAVESRLRRRELSPEARRSLEKELNELKEKLENNEKELKL 61 (85)
T ss_pred HHHHHHHHHHHHHHHcccCCChHHHHHHHHHHHHHHHHhhccHHHHHH
Confidence 344455555555555544557888899999999999999998888654
No 25
>PF00587 tRNA-synt_2b: tRNA synthetase class II core domain (G, H, P, S and T) This Prosite entry contains all class II enzymes. seryl tRNA synthetase structure; InterPro: IPR002314 The aminoacyl-tRNA synthetases (6.1.1. from EC) catalyse the attachment of an amino acid to its cognate transfer RNA molecule in a highly specific two-step reaction. These proteins differ widely in size and oligomeric state, and have limited sequence homology []. The 20 aminoacyl-tRNA synthetases are divided into two classes, I and II. Class I aminoacyl-tRNA synthetases contain a characteristic Rossman fold catalytic domain and are mostly monomeric []. Class II aminoacyl-tRNA synthetases share an anti-parallel beta-sheet fold flanked by alpha-helices [], and are mostly dimeric or multimeric, containing at least three conserved regions [, , ]. However, tRNA binding involves an alpha-helical structure that is conserved between class I and class II synthetases. In reactions catalysed by the class I aminoacyl-tRNA synthetases, the aminoacyl group is coupled to the 2'-hydroxyl of the tRNA, while, in class II reactions, the 3'-hydroxyl site is preferred. The synthetases specific for arginine, cysteine, glutamic acid, glutamine, isoleucine, leucine, methionine, tyrosine, tryptophan and valine belong to class I synthetases. The synthetases specific for alanine, asparagine, aspartic acid, glycine, histidine, lysine, phenylalanine, proline, serine, and threonine belong to class-II synthetases []. Based on their mode of binding to the tRNA acceptor stem, both classes of tRNA synthetases have been subdivided into three subclasses, designated 1a, 1b, 1c and 2a, 2b, 2c. This domain includes the glycine, histidine, proline, threonine and serine tRNA synthetases.; GO: 0000166 nucleotide binding, 0004812 aminoacyl-tRNA ligase activity, 0005524 ATP binding, 0006418 tRNA aminoacylation for protein translation, 0005737 cytoplasm; PDB: 3UH0_A 3UGT_C 3UGQ_A 1B76_B 1GGM_B 1ATI_A 1ADY_C 1ADJ_C 2I4O_A 2I4M_B ....
Probab=37.27 E-value=1.3e+02 Score=25.94 Aligned_cols=49 Identities=18% Similarity=0.293 Sum_probs=40.3
Q ss_pred CCCcHHHHHHHHHHHHHHHHHHHHcCC-eEEEEeeccCCCCCceEEEEEEe
Q 021200 74 GTGGEEASLFAVDVFKMYERYSQKKGW-KFEVVGVTESDLRGYKEASAAIS 123 (316)
Q Consensus 74 G~Gg~Ea~~~~~~L~~my~~~a~~~g~-~~~~~~~~~~~~~g~~~~~~~i~ 123 (316)
|.. .++..+...++..|..+...-|+ .+++.....++.++..+.+..++
T Consensus 118 ~~~-~~~~~~~~~~~~~~~~i~~~lgl~~~~~~~~~~~~~~~~~~~~~d~e 167 (173)
T PF00587_consen 118 CTP-EQSEEEFEELLELYKEILEKLGLEPYRIVLSSSGELGAYAKYEFDIE 167 (173)
T ss_dssp ESS-HHHHHHHHHHHHHHHHHHHHTTSGCEEEEEEETCTSCTTSSEEEEEE
T ss_pred eCC-cccHHHHHHHHHHHHHHHHHcCCceEEEEEcCCCccCCCHHHcccHH
Confidence 443 88999999999999999999999 99999988877766655555443
No 26
>PRK13562 acetolactate synthase 1 regulatory subunit; Provisional
Probab=36.27 E-value=88 Score=25.07 Aligned_cols=37 Identities=11% Similarity=0.122 Sum_probs=31.2
Q ss_pred HHHHHHHHcCCeEEEEeeccCCCCCceEEEEEEe-ccc
Q 021200 90 MYERYSQKKGWKFEVVGVTESDLRGYKEASAAIS-GVG 126 (316)
Q Consensus 90 my~~~a~~~g~~~~~~~~~~~~~~g~~~~~~~i~-G~~ 126 (316)
-....+.++||.++-+...+++..|+...++.+. |+.
T Consensus 18 Rit~lFsRRg~NI~SLtvg~Te~~~iSRmtivv~~~d~ 55 (84)
T PRK13562 18 RITSAFVRLQYNIDTLHVTHSEQPGISNMEIQVDIQDD 55 (84)
T ss_pred HHHHHHhccCcCeeeEEecccCCCCceEEEEEEeCCCH
Confidence 3445567899999999999999999999999997 754
No 27
>COG3881 PRC-barrel domain containing protein [General function prediction only]
Probab=35.81 E-value=58 Score=29.31 Aligned_cols=48 Identities=19% Similarity=0.195 Sum_probs=36.5
Q ss_pred HHcCCeEEEEeeccCCC-CCceEEEEEEeccccccceeeecceeEE-EEecc
Q 021200 96 QKKGWKFEVVGVTESDL-RGYKEASAAISGVGVYGKLKFESGIHRV-QRVPL 145 (316)
Q Consensus 96 ~~~g~~~~~~~~~~~~~-~g~~~~~~~i~G~~ay~~l~~E~GvHrv-~rvp~ 145 (316)
+-.|.. +++...+.. +.+..+++..+|+...++|-.+.|+|+- |.+|.
T Consensus 6 EleG~p--Vys~~tg~~lg~V~Dvif~~~gdrvl~flvnkggwfh~h~~lp~ 55 (176)
T COG3881 6 ELEGAP--VYSTKTGEKLGAVDDVIFNFSGDRVLGFLVNKGGWFHKHCCLPV 55 (176)
T ss_pred hhcCCc--eEEecccccccceeeEEEecCCCeEEEEEEecCcEEeeeeeeee
Confidence 334544 355554554 5599999999999999999999998766 88885
No 28
>KOG1489 consensus Predicted GTP-binding protein (ODN superfamily) [General function prediction only]
Probab=34.98 E-value=1.2e+02 Score=30.41 Aligned_cols=105 Identities=24% Similarity=0.325 Sum_probs=55.3
Q ss_pred eeEEEEcCCCcHHHHHHHHHHHHHHHHHHHHcCCeEEEEeeccCCCCCceEEEEEEeccccccceeeecceeEEEEeccc
Q 021200 67 CILEVRAGTGGEEASLFAVDVFKMYERYSQKKGWKFEVVGVTESDLRGYKEASAAISGVGVYGKLKFESGIHRVQRVPLT 146 (316)
Q Consensus 67 ~~leI~aG~Gg~Ea~~~~~~L~~my~~~a~~~g~~~~~~~~~~~~~~g~~~~~~~i~G~~ay~~l~~E~GvHrv~rvp~~ 146 (316)
-++.|.+|.||.=|.-|-.. |+.-.|-. +-..+..+| +|.+...- +++ +..++++-+.+.|.-
T Consensus 45 ~rv~~kgG~GG~G~ssf~~~-------~~~~~g~P----dGGdGG~GG--~V~~~a~~-~~~---~~l~~~~s~~~a~~G 107 (366)
T KOG1489|consen 45 RRVRIKGGSGGSGASSFFRG-------YRRPRGGP----DGGDGGNGG--HVYFVAKP-GAF---KQLSHVGSLIQAPNG 107 (366)
T ss_pred eeEEeeccCCCCccchhhhh-------cccccCCC----CCCCCCCCc--eEEEEeCc-ccc---cccccCCceEEccCC
Confidence 46999999999988755322 22211110 111122333 77776652 333 445577777777764
Q ss_pred cCCCCe--eeceeEEEEecCC--Cccc--------cccCCCCeEEEeeecCCCCC
Q 021200 147 EKSGRV--HTSAVSVAILPQA--DEVD--------VRLRNEDLRIDTYRSGGSGG 189 (316)
Q Consensus 147 ~~~gR~--hts~~~V~vlP~~--~~~~--------~~i~~~dl~~~~~RssGpGG 189 (316)
+..++. |-+++...+++.+ ..++ -+++..+-++-..| ||.||
T Consensus 108 e~~~s~~~~g~~ak~~~i~VP~Gt~v~d~~~~~~v~el~~~~~~~i~ar-GG~GG 161 (366)
T KOG1489|consen 108 ENGKSKMCHGSNAKHSEIRVPVGTVVKDIEQGKLVAELTKEGDRVIAAR-GGEGG 161 (366)
T ss_pred CcCccccccCCCcceEEEecCCccEEeecccchhHHHhccCCcEEEEee-cCCCC
Confidence 443332 3344443333333 2111 23456677788888 45777
No 29
>PF02815 MIR: MIR domain; InterPro: IPR003608 The MIR domain is named after three of the proteins in which it occurs: protein Mannosyltransferase (2.4.1.109 from EC), Inositol 1,4,5-trisphosphate receptor (IP3R) and Ryanodine receptor (RyR). MIR domains have also been found in eukaryotic stromal cell-derived factor 2 (SDF-2) and in Chlamydia trachomatis protein CT153. The MIR domain may have a ligand transferase function. This domain has a closed beta-barrel structure with a hairpin triplet, and has an internal pseudo-threefold symmetry. The MIR motifs that make up the MIR domain consist of ~50 residues and are often found in multiple copies. Inositol 1,4,5-trisphosphate (InsP3) is an intracellular second messenger that transduces growth factor and neurotransmitter signals. InsP3 mediates the release of Ca2+ from intracellular stores by binding to specific Ca2+ channel-coupled receptors. Ryanodine receptors are involved in communication between transverse-tubules and the sarcoplamic reticulum of cardiac and skeletal muscle. The proteins function as a Ca2+-release channels following depolarisation of transverse-tubules []. The function is modulated by Ca2+, Mg2+, ATP and calmodulin. Deficiency in the ryanodine receptor may be the cause of malignant hyperthermia (MH) and of central core disease of muscle (CCD) []. protein O-mannosyltransferases transfer mannose from DOL-P-mannose to ser or thr residues on proteins.; GO: 0016020 membrane; PDB: 1T9F_A 3UJ4_B 3UJ0_B 3T8S_B 3MAL_B 2XOA_A 1N4K_A.
Probab=34.30 E-value=64 Score=28.48 Aligned_cols=37 Identities=27% Similarity=0.408 Sum_probs=29.9
Q ss_pred EeeecCCCCCccccccCceEEEEeeCCceEEEEcCcC
Q 021200 180 DTYRSGGSGGQHANTTNSAVRVTHIPTGMTISIQDER 216 (316)
Q Consensus 180 ~~~RssGpGGQ~VNkt~saVrl~h~ptgi~v~~~~~R 216 (316)
+..-..|.++..+-..+|.+||.|..||..+.++..+
T Consensus 122 ~~~~~~~~~~~~~~~~~s~frL~H~~t~~~L~~~~~~ 158 (190)
T PF02815_consen 122 EEKSSTGMGEDEIKTLDSYFRLRHVATGCWLHSHDVK 158 (190)
T ss_dssp EEEESSSCSSSSBBBTTSEEEEEETTTTEEEEEEEEE
T ss_pred EecccCCccCCcEEecccEEEEEECCcCEEEecCCcc
Confidence 3444567778888888999999999999988887755
No 30
>PRK06342 transcription elongation factor regulatory protein; Validated
Probab=34.03 E-value=95 Score=27.48 Aligned_cols=52 Identities=8% Similarity=0.136 Sum_probs=36.0
Q ss_pred HHHHHHHHHHHHHHHhHhhcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhC
Q 021200 5 SELRTKQKEIDGLKSLIYECSEDKDMLDMATEELCLAIDEEKRLQSLLLKSLL 57 (316)
Q Consensus 5 ~~~~~~~~el~el~~l~~e~~~D~em~e~a~eE~~~l~~~l~~le~~l~~~ll 57 (316)
+-|..++++|+.|++-+.+.-..-|+.+ ++++...++.++..|+..|..+-+
T Consensus 34 ~G~~~L~~El~~L~~~i~~Ar~~GDlsE-ak~~~~~~e~rI~~L~~~L~~A~I 85 (160)
T PRK06342 34 AGLKALEDQLAQARAAYEAAQAIEDVNE-RRRQMARPLRDLRYLAARRRTAQL 85 (160)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHCCChhH-HHHHHHHHHHHHHHHHHHHccCEE
Confidence 4577778888887765533222233444 888888898999999988877654
No 31
>PF11553 DUF3231: Protein of unknown function (DUF3231); InterPro: IPR021617 This bacterial family of proteins has no known function. ; PDB: 2RBD_B.
Probab=33.91 E-value=2.6e+02 Score=24.17 Aligned_cols=55 Identities=24% Similarity=0.290 Sum_probs=39.2
Q ss_pred HHHHHHHHHHHHHHHHHhHhhcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCC
Q 021200 3 LISELRTKQKEIDGLKSLIYECSEDKDMLDMATEELCLAIDEEKRLQSLLLKSLLP 58 (316)
Q Consensus 3 ~~~~~~~~~~el~el~~l~~e~~~D~em~e~a~eE~~~l~~~l~~le~~l~~~llp 58 (316)
.|..|....--+.-+.-+++- -.|+|++.+++.-++...++++.+++.+...=+|
T Consensus 22 Lw~~~~~~~~~~~~~~~f~~~-~~D~dik~~l~~~~~~~~~~i~~l~~ll~~e~ip 76 (166)
T PF11553_consen 22 LWNNYMANYMSICLLQYFLQV-AEDKDIKKLLKKGLDLSQKQIEQLEKLLKEEGIP 76 (166)
T ss_dssp HHHHHHHHHHHHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHHHHHHHHHHHH-cCCHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 456666666666666666654 4799999999999999999999999888776443
No 32
>PF14257 DUF4349: Domain of unknown function (DUF4349)
Probab=32.89 E-value=1.7e+02 Score=27.27 Aligned_cols=49 Identities=22% Similarity=0.213 Sum_probs=34.2
Q ss_pred HHHHHHHHHHHHHHHHHhHhhcCCCHHHHHHHHHHHHHHHHHHHHHHHHH
Q 021200 3 LISELRTKQKEIDGLKSLIYECSEDKDMLDMATEELCLAIDEEKRLQSLL 52 (316)
Q Consensus 3 ~~~~~~~~~~el~el~~l~~e~~~D~em~e~a~eE~~~l~~~l~~le~~l 52 (316)
.-.++++++...+.|.+|+...+ +.+=.-.++.++..++.+++.++..+
T Consensus 137 ~~arl~~l~~~~~rl~~ll~ka~-~~~d~l~ie~~L~~v~~eIe~~~~~~ 185 (262)
T PF14257_consen 137 LEARLKNLEAEEERLLELLEKAK-TVEDLLEIERELSRVRSEIEQLEGQL 185 (262)
T ss_pred HHHHHHHHHHHHHHHHHHHHhcC-CHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 34567778888888888886544 33333347778888888888887665
No 33
>PRK05431 seryl-tRNA synthetase; Provisional
Probab=31.07 E-value=2.7e+02 Score=28.26 Aligned_cols=69 Identities=20% Similarity=0.257 Sum_probs=0.0
Q ss_pred ChHHHHHHHHHHHHHHHHHhH-----------hhcCCCHHHHHHH---HHHHHHHHHHHHHHHHHHHHhhC---------
Q 021200 1 MHLISELRTKQKEIDGLKSLI-----------YECSEDKDMLDMA---TEELCLAIDEEKRLQSLLLKSLL--------- 57 (316)
Q Consensus 1 ~~~~~~~~~~~~el~el~~l~-----------~e~~~D~em~e~a---~eE~~~l~~~l~~le~~l~~~ll--------- 57 (316)
+.++++++++..+++.+..-. ...++..++++.+ ++++..+++++..++.++...++
T Consensus 31 ~~ld~~~r~l~~~~~~lr~~rn~~sk~i~~~~~~~~~~~~l~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~iPN~~~~~ 110 (425)
T PRK05431 31 LELDEERRELQTELEELQAERNALSKEIGQAKRKGEDAEALIAEVKELKEEIKALEAELDELEAELEELLLRIPNLPHDS 110 (425)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCCCcc
Q ss_pred -CCCCCccCCeeE
Q 021200 58 -PKDDADERDCIL 69 (316)
Q Consensus 58 -p~~~~d~~~~~l 69 (316)
|.++.++.+.+|
T Consensus 111 vP~g~~~~~n~~i 123 (425)
T PRK05431 111 VPVGKDEDDNVEV 123 (425)
T ss_pred CCCCCCCCCceEE
No 34
>PF15466 DUF4635: Domain of unknown function (DUF4635)
Probab=29.08 E-value=25 Score=30.12 Aligned_cols=47 Identities=30% Similarity=0.439 Sum_probs=34.6
Q ss_pred CCceeEeecCCCceeeccccceecCccc----ccCC---cChHHHHHHHHHHHH
Q 021200 259 SERIRTYNFPQGRVTDHRVGITHHAISD----MMEG---ENLDIFIDALLLQQE 305 (316)
Q Consensus 259 se~IRtYnf~~~rVtDhR~~~~~~~l~~----vl~G---~~ld~~i~~l~~~~~ 305 (316)
|++||--||+||-|+..-..+.+.+... +|.- ++|+-|.+.|...-+
T Consensus 55 serireCN~~QN~v~sqg~EyQt~epseEPik~~r~WLkenLhvflEkLE~Evr 108 (135)
T PF15466_consen 55 SERIRECNYYQNPVASQGFEYQTKEPSEEPIKAIRNWLKENLHVFLEKLEKEVR 108 (135)
T ss_pred HhhhhhcCCcCCcccccccccccCCCccchHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 5799999999999999888777766432 3332 468888888765443
No 35
>PF13450 NAD_binding_8: NAD(P)-binding Rossmann-like domain; PDB: 3KA7_A 1V0J_D 3INR_B 3KYB_B 3GF4_A 2BI8_A 3INT_B 1WAM_A 2BI7_A 3MJ4_G ....
Probab=27.92 E-value=1.2e+02 Score=22.45 Aligned_cols=36 Identities=25% Similarity=0.482 Sum_probs=22.9
Q ss_pred HcCCeEEEEeeccCCCCC-ceEEEEEEeccccccceeeecceeEEE
Q 021200 97 KKGWKFEVVGVTESDLRG-YKEASAAISGVGVYGKLKFESGIHRVQ 141 (316)
Q Consensus 97 ~~g~~~~~~~~~~~~~~g-~~~~~~~i~G~~ay~~l~~E~GvHrv~ 141 (316)
+.|+++.++|.... .+| ..+... .| ...+.|.|.+.
T Consensus 17 ~~g~~v~v~E~~~~-~GG~~~~~~~--~g------~~~d~g~~~~~ 53 (68)
T PF13450_consen 17 KAGYRVTVFEKNDR-LGGRARSFRI--PG------YRFDLGAHYFF 53 (68)
T ss_dssp HTTSEEEEEESSSS-SSGGGCEEEE--TT------EEEETSS-SEE
T ss_pred HCCCcEEEEecCcc-cCcceeEEEE--CC------EEEeeccEEEe
Confidence 34999999997744 344 444433 33 57889988774
No 36
>smart00322 KH K homology RNA-binding domain.
Probab=23.18 E-value=1.3e+02 Score=20.63 Aligned_cols=45 Identities=22% Similarity=0.353 Sum_probs=27.2
Q ss_pred CCCCcccccc--CceEEEEeeCCc---eEEEEcCcCcHHHHHHHHHHHHHHHH
Q 021200 186 GSGGQHANTT--NSAVRVTHIPTG---MTISIQDERSQHMNKAKALKVLCAKL 233 (316)
Q Consensus 186 GpGGQ~VNkt--~saVrl~h~ptg---i~v~~~~~RSq~~Nk~~A~~~L~~~L 233 (316)
|++|.+++.. .+.+++.-.+.+ -++..... ..+...|...|...+
T Consensus 19 G~~G~~i~~i~~~~~~~i~~~~~~~~~~~v~i~g~---~~~v~~a~~~i~~~~ 68 (69)
T smart00322 19 GKGGSTIKKIEEETGVKIDIPEDGSEERVVEITGP---PENVEKAAELILEIL 68 (69)
T ss_pred CCCchHHHHHHHHHCCEEEECCCCCCccEEEEEcC---HHHHHHHHHHHHHHh
Confidence 7899888753 345555443322 44555543 577777877777654
No 37
>cd05569 PTS_IIB_fructose PTS_IIB_fructose: subunit IIB of enzyme II (EII) of the fructose-specific phosphoenolpyruvate:carbohydrate phosphotransferase system (PTS). In this system, EII (also referred to as FruAB) is a fructose-specific permease made up of two proteins (FruA and FruB) each containing 3 domains. The FruA protein contains two tandem nonidentical IIB domains and a C-terminal IIC transmembrane domain. Both IIB domains of FruA are included in this alignment. The FruB protein (also referred to as diphosphoryl transfer protein) contains a IIA domain, a domain of unknown function, and an Hpr-like domain called FPr (fructose-inducible HPr). This familiy also includes the IIB domains of several fructose-like PTS permeases including the Frv permease encoded by the frvABXR operon, the Frw permease encoded by the frwACBD operon, the Frx permease encoded by the hrsA gene, and the Fry permease encoded by the fryABC (ypdDGH) operon. FruAB takes up exogenous fructose, releasing the 1-p
Probab=21.70 E-value=2.4e+02 Score=22.41 Aligned_cols=37 Identities=22% Similarity=0.319 Sum_probs=27.0
Q ss_pred eEEEEcCCCcHHHHHHHHHHHHHHHHHHHHcCCeEEEEeec
Q 021200 68 ILEVRAGTGGEEASLFAVDVFKMYERYSQKKGWKFEVVGVT 108 (316)
Q Consensus 68 ~leI~aG~Gg~Ea~~~~~~L~~my~~~a~~~g~~~~~~~~~ 108 (316)
++-+..|.|...+-+.+ ++..++|+.+||++.+.-..
T Consensus 2 ~~i~ac~~G~a~s~laa----~~L~~aa~~~g~~~~ve~~~ 38 (96)
T cd05569 2 VAVTACPTGIAHTYMAA----EALEKAAKKLGWEIKVETQG 38 (96)
T ss_pred EEEEECCCchhHHHHHH----HHHHHHHHHCCCeEEEEEec
Confidence 45577888888777544 45668999999998766433
No 38
>PF08014 DUF1704: Domain of unknown function (DUF1704); InterPro: IPR012548 This family contains many hypothetical proteins.
Probab=21.19 E-value=2.8e+02 Score=27.62 Aligned_cols=123 Identities=19% Similarity=0.152 Sum_probs=66.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHHHHH-------HHHhhC--CCCCCc-cCCeeEEEE-------cCCCcHHHHHHHHHH
Q 021200 25 SEDKDMLDMATEELCLAIDEEKRLQSL-------LLKSLL--PKDDAD-ERDCILEVR-------AGTGGEEASLFAVDV 87 (316)
Q Consensus 25 ~~D~em~e~a~eE~~~l~~~l~~le~~-------l~~~ll--p~~~~d-~~~~~leI~-------aG~Gg~Ea~~~~~~L 87 (316)
.+|+.+..+..+-++++...+.-|+.. ....+. |++..- ....|++.. ...-...|..++..+
T Consensus 39 ~~d~~l~~l~~~~~~e~~~~i~mL~~~Gt~~F~~~S~~lYG~p~~~~~~~A~~il~~~~~~~~~~~~~~~~~a~~~~~~~ 118 (349)
T PF08014_consen 39 IEDPPLGQLYRDKIDEYDLQIDMLEARGTPDFYYNSLRLYGEPSDKFIANAKFILELALEESYEEEEEKTLDAEEAVSRL 118 (349)
T ss_pred cCCchHHHHHHHHHHHHHHHHHHHHhcCchHHHHHHHHHhCCCChhhhhccHHHHHhhhhcccccccccCCCHHHHHHHH
Confidence 467889998888888887777666531 111122 222211 111122222 122234566677777
Q ss_pred HHHHHHHHHHcC--CeEEEEeeccCC-CCCceEEEEEEeccc------cccceeeecceeEEEEeccccCCCCeee
Q 021200 88 FKMYERYSQKKG--WKFEVVGVTESD-LRGYKEASAAISGVG------VYGKLKFESGIHRVQRVPLTEKSGRVHT 154 (316)
Q Consensus 88 ~~my~~~a~~~g--~~~~~~~~~~~~-~~g~~~~~~~i~G~~------ay~~l~~E~GvHrv~rvp~~~~~gR~ht 154 (316)
-++..+|..+.+ +++++-+...+. ..|-.. +.|.-.. +.+.+.+|.|||=+ |.-+|+.|.
T Consensus 119 ~~~~~~y~~~~~~~~~V~~sddl~a~A~v~~~~--l~I~~~~~fs~~~l~~L~~HEigvH~l-----t~~Ng~~QP 187 (349)
T PF08014_consen 119 QERLKKYFGKEGFEVKVELSDDLLARAMVSGDR--LKINKNAMFSERDLEALLHHEIGVHLL-----TTLNGRAQP 187 (349)
T ss_pred HHHHHHHhcccCceEEEEEcCCcchhhcccCCe--eEEcCCCCcCHHHHHHHHHHhhhhhhc-----cccccccCC
Confidence 777778877664 444444322222 112122 5554333 34889999999943 455666665
No 39
>PRK11020 hypothetical protein; Provisional
Probab=21.13 E-value=5.2e+02 Score=22.05 Aligned_cols=46 Identities=15% Similarity=0.211 Sum_probs=32.4
Q ss_pred HHHHHHHHHHHHHHHhHh--hcCCCHHHHHHHHHHHHHHHHHHHHHHH
Q 021200 5 SELRTKQKEIDGLKSLIY--ECSEDKDMLDMATEELCLAIDEEKRLQS 50 (316)
Q Consensus 5 ~~~~~~~~el~el~~l~~--e~~~D~em~e~a~eE~~~l~~~l~~le~ 50 (316)
.+++.+...|..+..-+. ....|.++...+..|++.+..+|..+..
T Consensus 5 ~Eiq~L~drLD~~~~Klaaa~~rgd~~~i~qf~~E~~~l~k~I~~lk~ 52 (118)
T PRK11020 5 NEIKRLSDRLDAIRHKLAAASLRGDAEKYAQFEKEKATLEAEIARLKE 52 (118)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHHHHHHHHHH
Confidence 345555555555555331 2256999999999999999999887754
No 40
>cd07881 RHD-n_NFAT N-terminal sub-domain of the Rel homology domain (RHD) of nuclear factor of activated T-cells (NFAT) proteins. Proteins containing the Rel homology domain (RHD) are metazoan transcription factors. The RHD is composed of two structural sub-domains; this model characterizes the N-terminal RHD sub-domain of the NFAT family of transcription factors. NFAT transcription complexes are a target of calcineurin, a calcium dependent phosphatase, and activate genes that are mainly involved in cell-cell interaction. Upon de-phosphorylation of the nuclear localization signal, NFAT enters the nucleus and acts as a transcription factor; its export from the nucleus is triggered by phosphorylation via export kinases. NFATs play important roles in mediating the immune response, and are found in T cells, B Cells, NK cells, mast cells, and monocytes. NFATs are also found in various non-hematopoietic cell types, where they play roles in development.
Probab=21.05 E-value=1.5e+02 Score=26.59 Aligned_cols=26 Identities=38% Similarity=0.703 Sum_probs=17.6
Q ss_pred CCccccccCceEEEE---eeC--CceEEEEc
Q 021200 188 GGQHANTTNSAVRVT---HIP--TGMTISIQ 213 (316)
Q Consensus 188 GGQ~VNkt~saVrl~---h~p--tgi~v~~~ 213 (316)
|+.-+-|-+|.||+. ||| .|-+++.|
T Consensus 134 getd~~rk~Tr~RlvFRv~Ip~~~G~~~sLQ 164 (175)
T cd07881 134 GETDIGRKNTRVRLVFRVHIPQPSGRVLSLQ 164 (175)
T ss_pred ccCCccccccEEEEEEEEeccCCCCCEEEEE
Confidence 555566889999995 665 57555444
No 41
>cd02394 vigilin_like_KH K homology RNA-binding domain_vigilin_like. The vigilin family is a large and extended family of multiple KH-domain proteins, including vigilin, also called high density lipoprotein binding protien (HBP), fungal Scp160 and bicaudal-C. Yeast Scp160p has been shown to bind RNA and to associate with both soluble and membrane-bound polyribosomes as a mRNP component. Bicaudal-C is a RNA-binding molecule believed to function in embryonic development at the post-transcriptional level. In general, KH binds single-stranded RNA or DNA. It is found in a wide variety of proteins including ribosomal proteins, transcription factors and post-transcriptional modifiers of mRNA.
Probab=20.94 E-value=1.2e+02 Score=21.49 Aligned_cols=20 Identities=15% Similarity=0.353 Sum_probs=14.5
Q ss_pred CCCCcccccc--CceEEEEeeC
Q 021200 186 GSGGQHANTT--NSAVRVTHIP 205 (316)
Q Consensus 186 GpGGQ~VNkt--~saVrl~h~p 205 (316)
|+||.++++. ++.|+|.-.+
T Consensus 16 G~~G~~i~~i~~~~g~~I~i~~ 37 (62)
T cd02394 16 GKKGSNIRKIMEETGVKIRFPD 37 (62)
T ss_pred CCCCCcHHHHHHHhCCEEEcCC
Confidence 7999999953 4677776544
No 42
>PF02185 HR1: Hr1 repeat; InterPro: IPR000861 The HR1 repeat was first described as a three times repeated homology region of the N-terminal non-catalytic part of protein kinase PRK1(PKN) []. The first two of these repeats were later shown to bind the small G protein rho [, ] known to activate PKN in its GTP-bound form. Similar rho-binding domains also occur in a number of other protein kinases and in the rho-binding proteins rhophilin and rhotekin. Recently, the structure of the N-terminal HR1 repeat complexed with RhoA has been determined by X-ray crystallography []. It forms an antiparallel coiled-coil fold termed an ACC finger. This entry includes domains found within rho-associated protein kinases.; GO: 0007165 signal transduction, 0005622 intracellular; PDB: 1CXZ_B 3O0Z_C 2RMK_B 1URF_A.
Probab=20.56 E-value=3.6e+02 Score=19.98 Aligned_cols=54 Identities=20% Similarity=0.195 Sum_probs=36.8
Q ss_pred HHHHHHHHHHHHHHHHhHhhcCCCHH-HHHHHHHHHHHHHHHHHHHHHHHHHhhC
Q 021200 4 ISELRTKQKEIDGLKSLIYECSEDKD-MLDMATEELCLAIDEEKRLQSLLLKSLL 57 (316)
Q Consensus 4 ~~~~~~~~~el~el~~l~~e~~~D~e-m~e~a~eE~~~l~~~l~~le~~l~~~ll 57 (316)
..++..-.+-++.++.|+.-...|.. .+..+..++.....++..|+..|....-
T Consensus 7 ~~~i~~E~ki~~Gae~m~~~~~t~~~~~~~~~~~~l~~s~~kI~~L~~~L~~l~~ 61 (70)
T PF02185_consen 7 QKKIDKELKIKEGAENMLQAYSTDKKKVLSEAESQLRESNQKIELLREQLEKLQQ 61 (70)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHCCHHCH-HHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHHHHccCcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 34455555566677777763224554 4888999999999999998888766543
Done!